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Overview and General Introduction 
 
Overview 
Drug resistant bacterial infections pose a serious hurdle to effective healthcare 
today. Multi-drug resistant infections are becoming more widespread which further 
complicates patient care. If a bacterium develops resistance to one antimicrobial, it is far 
more likely to develop resistance to other drugs (Gould, 2008). In patients with drug 
resistant infections, morbidity, mortality and hospital costs virtually double compared to 
patients with susceptible organisms (French, 2010; Gould, 2009; Livermore, 2007). The 
emergence and spread of antibiotic resistance is a complex issue with many contributing 
factors, including frequent antibiotic exposure, antibiotic use in industrial agriculture, 
ease of international travel, current antibiotic prescribing practices, and less than optimal 
infection control and hygiene.  
To better understand the origins and emergence of antibiotic resistance in clinical 
pathogens, bacteria in the environment must be considered to elucidate transmission of 
resistance determinants between genera and species. For example, plasmid-mediated, 
fluoroquinolone resistance is suspected to have originated in aquatic bacteria living in 
polluted water systems. However, the fluoroquinolones are not the only class of 
antibiotics for which resistance has emerged in an environmental setting. Some resistance 
to aminoglycosides, via a methylase enzyme, is hypothesized to have originated in 
environmental Actinomycetes known to produce this class of drugs. Combined with 
exposure through industrial agriculture, it is easy to see how resistance to 
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aminoglycosides could be facilitated leading to more widespread dissemination in the 
environment (Gould, 2008). Additionally, extended spectrum β-lactamase (ESBLs) 
enzymes, now a major hurdle in the treatment of Gram-negative bacterial infections, 
originated in Kluyvera species, a genus of environmental bacteria of little clinical 
importance (Pfeifer, 2010; Livermore, 2006). Yet, the transfer of ESBLs is so widespread 
now, that nearly all β-lactam antibiotics are affected, hindering our ability to treat serious 
Gram-negative infections.  
These are merely a few examples of the environment acting as a reservoir for 
potentially disastrous, transferable resistance determinants. It has been well established 
that clinically important human pathogens can acquire novel resistance from 
environmental bacteria (French, 2010). If we hope to further our understanding of the 
emergence of antibiotic resistance and prevent future development of resistance, the 
complicity of the environment should not be overlooked or underestimated. 
In addition to preventing further spread of antimicrobial resistance, new drugs are 
sorely needed, both to help in fighting antibiotic resistant infections that continue to 
occur, but also to help reduce the selection pressure caused by frequent use of the same 
antibiotics time and time again. With antibiotic development currently at a stand-still, 
new approaches are desperately needed for discovery of novel agents. For this reason, we 
looked to the past, specifically the ancient past, for possible novel drugs and/or 
identification of drug targets.  In antiquity, essential oils were used to combat a large 
number of maladies, including infections. Many historical documents as well as current 
studies have demonstrated the potent activity of various essential oils against a select 
number of bacterial pathogens. With the advent of modern techniques such as gas 
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chromatography-mass spectrometry, we are learning about the intricate complexities of 
essential oils and the potent components contained in their mixtures. These components 
are in essence concentrated mixtures of secondary metabolites from various plant 
structures, including stems, flowers, leaves, and seeds. The function of these mixtures, 
from the plant’s point of view, are for protection from bacterial, fungal, and viral 
pathogens. Thus, due to the sheer variety of bacteria in the environment and the multitude 
of plants already producing antimicrobial compounds, it is likely that novel 
antimicrobials with unique mechanisms of action have yet to be discovered. By studying 
the antimicrobial activity of a large number of essential oils in tandem with a wide range 
of bacteria and fungi, it may be possible to discern patterns of oil-organism specific 
activity indicative of a unique mechanism of action. To the best of our knowledge, this 
thesis represents the first study of its type in which over 80, highly purified essential oils 
have been tested against a wide array of both susceptible and multi-drug resistant Gram-





Antibiotic resistance is defined as microbial survival despite exposure to 
antibiotics designed to eliminate them. Increasing resistance to antibiotics is a critical 
issue and leads to significant morbidity and mortality and increased healthcare 
expenditures worldwide (Hogberg, 2010; Khameneh, 2016). There are several reasons for 
the increase in microbial resistance now being encountered across the globe. Antibiotics 
have been over-prescribed and used inappropriately, by physicians, patients, or in 
industrial agriculture. Additionally, antibiotic research and development has stalled. The 
end result, resistance has developed to many key antibiotics in our current arsenal, some 
of which were held in reserve for treatment of drug resistant infections. Unfortunately, 
these once curable infections are now virtually untreatable, returning us in many respects 
to the pre-antibiotic era.   
 Bacterial resistance to antibiotics may be due to a number of factors including 
intrinsic resistance, acquired resistance, modification of a drug target, enhanced drug 
efflux, decreased permeability, loss of enzymes required for pro-drug metabolism, and 
enzymatic inactivation of the antibiotic (Andersson, 2003; Khameneh, 2016).  
Intrinsic versus acquired resistance. Intrinsic resistance to antibiotics refers to an 
innate, chromosomally encoded ability of a bacterium to escape the effects of antibiotics. 
Acquired resistance, or resistance that the bacterium would not naturally possess, may be 
the result of mutations in the bacterial chromosome or the uptake of exogenous genetic 
material, like plasmids. Acquired resistance may be spread from one bacterium to another 
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through horizontal gene transfer. There are three known methods of horizontal gene 
transfer: conjugation, transduction, and transformation. Conjugation involves the copy 
and transfer of genetic material between bacterial cells via an F-pilus. Transduction 
occurs when a bacterial virus, or bacteriophage, mistakenly takes a portion of the 
bacterial DNA with its own as it assembles inside the bacterial cell, and then inserts that 
DNA into another bacterium during the infection process. Finally, transformation is the 
uptake of free DNA from the cell’s external environment. Both intrinsic resistance and 
acquired resistance mechanisms may be inducible or constitutively expressed, and may 
encode either low-level or high-level resistance phenotypes. 
 Drug target modification. Modification of a drug target refers to functional or 
structural changes to the target enzyme or receptor for the antibiotic that either prevents 
binding or decreases binding affinity. One example of this type of resistance is the cfr 
gene in Staphylococcus species. This gene confers resistance to multiple antibiotics by 
production of an RNA methyltransferase, which methylates an adenine residue in the 23S 
ribosomal RNA gene. This results in a change within the bacterium that interferes with 
the correct binding activity of the antibiotic, which ultimately renders the antibiotic 
ineffective. Classes of antibiotics affected by the cfr gene include protein synthesis 
inhibitors such as phenicols (e.g. chloramphenicol), and oxazolidinones (e.g. linezolid) 
(Shen, 2013). Both chloramphenicol and linezolid inhibit protein synthesis through their 
interactions with the 50S subunit of the bacterial ribosome. Modification of the drug 
target can also circumvent the action of antibiotics that function through other 
mechanisms of action. An example of this is vanA mediated vancomycin resistance in 
Gram-positive bacteria, primarily Enterococcus faecalis and Enterococcus faecium, but 
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also rarely observed in Staphylococcus species. Vancomycin is a cell wall synthesis 
inhibitor that works by preventing transpeptidation and transglycosylation of 
peptidoglycan through binding of the D-Ala-D-Ala peptidoglycan precursor molecules. 
In the presence of the vanA operon, the D-Ala-D-Ala portion of these precursors to 
peptidoglycan are altered to D-Ala-D-Lac, resulting in a loss of the intended drug target, 
and an inability of vancomycin to bind, resulting in decreased antimicrobial effectiveness 
(Xia, 2016). Another antibiotic class that interferes with cell wall synthesis are the β-
lactams, and the mecA gene in Staphylococcus aureus is notorious for conferring 
resistance to methicillin (MRSA) through modification of the penicillin binding protein 
domain that the drug is intended to interact with. 
 Enhanced drug efflux. Enhancement of drug efflux is the ability of the bacterial 
cell to pump the antibiotic out before it can exert its inhibitory effect. There are five 
families of efflux pumps, some occurring in all bacteria and others that are specifically 
found in either Gram-positive or Gram-negative organisms. While efflux pump-mediated 
antibiotic resistance may be found in both Gram-positive and Gram-negative bacteria, it 
is more common in Gram-negative organisms, and can underlie multi-drug resistance in 
the Enterobacteriaceae. In addition, Pseudomonas aeruginosa, a non-enteric, Gram-
negative bacteria, has fluoroquinolone resistance, which is mediated through the use of 
enhanced efflux activities (Khameneh, 2016). Fluoroquinolones, such as ciprofloxacin, 
target nucleic acid synthesis and interfere with topoisomerase as well as DNA gyrase, 
enzymes in the nucleic acid synthesis pathway. Enhanced efflux is also another facet of 
resistance to β-lactam antibiotics in Gram-negative bacteria. 
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 Decreased Permeability. Decreased cellular permeability to antibiotic agents is an 
important cause of antibiotic resistance in enteric pathogens such as Escherichia coli and 
Enterobacter aerogenes. This occurs due to altered porin expression on the bacterial 
outer membrane resulting from overexpression of the marA gene. Overexpression of this 
gene hinders the ability of the antibiotic to penetrate the bacterial cell, conferring 
resistance to several antibiotics, including β-lactams, such as penicillin and imipenem 
(Bornet, 2000; Davin-Regli, 2008). This is merely one of many mechanisms of resistance 
to β-lactam antibiotics, which function through inhibition of cell wall synthesis by 
interference with the structural integrity of peptidoglycan. Another example of decreased 
cellular permeability conferring resistance to antibiotic therapy exists in Pseudomonas 
aeruginosa. Transcriptional down-regulation of or mutations in oprD, which encodes cell 
membrane porin proteins in Pseudomonas, results in decreased or deformed cellular 
membrane porin production, leading to decreased cellular permeability and a lessened 
ability for antibiotics to penetrate the bacterium. 
 Loss of enzymes in prodrug metabolism. With certain antibiotics, known as ‘pro-
drugs’, an enzymatic processing of the molecule must occur by the bacterium in order for 
the drug to become active and exert an antimicrobial effect. One example of this 
mechanism involves isoniazid, an inhibitor of mycolic acid synthesis and a first-line drug 
used for the treatment of tuberculosis. Mycolic acids are a highly specific drug target, and 
a critical component of Mycobacterial cell wall structure. The katG gene in 
Mycobacterium tuberculosis encodes a catalase-peroxidase enzyme needed for the 
activation of isoniazid. When mutations occur in katG, enzymatic activation of the 
prodrug fails, resulting in isoniazid resistance (Huang, 2013; Zhang, 1992). 
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 Enzymatic inactivation of antibiotics. Antibiotic inactivation refers to the process 
by which a bacterium is able to detoxify, or render harmless, an otherwise harmful 
substance by enzymatic modification of the drug. Lincosamide resistance in 
Staphylococcus species, such as resistance to clindamycin, a protein synthesis inhibitor 
that acts through interference with the 50S ribosomal subunit’s peptidyltransferase, can 
occur through this mechanism, mediated by the linA and linB genes. The linA and linA’ 
genes code for nucleotidyltransferases that result in the conversion of clindamycin to 
clindamycin 4-(5’-adenylate) (Yildiz, 2014; Bozdogan, 1999). The linB gene, first 
identified in Enterococcus faecium, has a similar function, producing a 
nucleotidyltransferase that converts clindamycin to clindamycin 3-(5’-adenylate) 
(Bozdogan, 1999). This enzymatic alteration of clindamycin results in a loss of 
antimicrobial function. Enzymatic inactivation is also one of the primary resistance 
mechanisms employed by bacteria against β-lactam antibiotics (Sandanayaka, 2002) Well 
known β-lactam antibiotics include penams/penicillins (e.g. ampicillin), cephalosporins 
(e.g. ceftaroline, ceftriaxone, cefepime, etc.), monobactams (e.g. aztreonam), and 
carbapenems (e.g. imipenem). Enzymatic modification of β-lactams occurs primarily 
through production of β-lactamase (or carbapenemase) enzymes in Gram-negative 
bacteria. β-lactamase enzymes can be classified into two main groups: serine β-
lactamases (classes A, C, and D) which have a serine amino acid in the active site and 
metallo-β-lactamases (class B) which typically have zinc or another bivalent cation in 
their active site (Livermore, 2006; Pfeifer, 2010). These enzymes inactivate β-lactams by 
cleaving the ring structure at the amide bond. Specifically, traditional β-lactamases can 
confer resistance to penicillins and early cephalosporins (Pfeifer, 2010). Extended 
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spectrum β-lactamases are able to hydrolyze more β-lactams than typical β-lactamases, 
potentially conferring resistance to penicillins, most cephalosporins, and monobactams 
(Falagas, 2009). Finally, carbapenemases have the ability to confer pan-resistance to β-
lactam antibiotics. A few notable examples of β-lactamases include AmpC, KPC, and 
more recently, NDM-1.  
 AmpC is an inducible β-lactamase that may confer low-level resistance due to 
lower expression, as is the case in E. coli. AmpC expression may also result in more 
severe resistance, as in E. cloacae, or may be completely silent due to deficiency of the 
gene, as noted in Klebsiella species (Xia, 2016). This form of β-lactamase enables Gram-
negative bacteria to become resistant to cephamycins and third generation cephalosporin 
antibiotics (Pfeifer, 2010). 
 KPC β-lactamase, specifically carbapenemases, are of great concern, as these 
enzymes essentially confer pan-resistance to β-lactam antibiotics. None of the antibiotics 
within the β-lactam class are expected to be effective against a bacterium possessing a 
KPC enzyme (Livermore, 2006). These enzymes are serine-based, β-lactamases, utilizing 
the serine residue in their active site to hydrolyze β-lactam antibiotics. 
 One final, and critical, example of β-lactamase enzymes is the NDM-1, a class B 
metallo-β-lactamase. Metallo-β-lactamases are unique, in that β-lactamase inhibitors are 
unable to inhibit them because they do not directly interact with the β-lactam ring 
structure. Characteristically, these enzymes confer resistance to all β-lactams including 
carbapenems, once held in reserve as a last line of defense for β-lactam resistant 
organisms. Only the monobactams such as aztreonam have some activity against positive 
for NDM-1. This may, however, cease to matter in the future, as clinical isolates have 
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begun to emerge that carry a sufficient multitude of β-lactamase enzymes rendering them 
pan-resistant (Walsh, 2010). NDM-1 is of particular concern, because it is found on a 
plasmid which carries a staggering amount of other resistance determinants, including 
monobactams, aminoglycosides, macrolides, rifampin, and sulfamethoxazole. 
 
Investigating Antibiotic Resistance 
Antibiotic resistance has become an ever-increasing reality that has now reached a 
critical juncture. The speed and magnitude with which antibiotic resistance has developed 
necessitates a greater understanding of the true sources of this resistance. While previous 
antibiotic exposure is known to be a contributing factor to the emergence of resistance, 
this is not the whole story. Horizontal gene transfer can enable the spread of resistance 
determinants from one bacterium to another. Many organisms, including environmental 
bacteria, are known to produce antimicrobial compounds as defense mechanisms. These 
bacteria have to be resistant to the antimicrobial substances they produce in order to 
survive, and additionally, other bacteria may develop coping mechanisms to survive in 
the presence of these compounds, without man-made antibiotic selection pressure. From 
this, it may be inferred that bacteria within the environment exist as a reservoir for 
antibiotic resistance, and also possess the potential to spread this resistance to bacteria 
that are relevant in human infection. Ultimately, we can conclude that antibiotic 
resistance in bacteria from the environment warrants further investigation to fully 
understand its relevance and possible significance as a reservoir for drug resistance genes 
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Background. Antibiotic resistant Gram-positive bacteria have been found in 
coastal and polluted waters. The Chesapeake Bay (CB) and connected rivers are subject 
to runoff from many sources including industrial agriculture. We sought to identify 
antibiotic resistance in Gram-positive isolates recovered from 10 sites in the CB and 
associated rivers. 
Methods. Water samples were collected during the summer of 2012 from 10 sites 
based on proximity to industrial agriculture, sewage effluents, and common runoff.  
Water samples were vacuum filtered and the filter paper incubated in T-soy broth. Gram-
positive isolates were identified to the species level using MALDI-TOF MS. Antibiotic 
susceptibility testing was performed using E-test. 
Results. A total of 142 unique Gram-positive isolates were recovered from all 
sites considered together representing 4 primary genera: Bacillus (n = 95), Lactococcus 
(n = 10), Staphylococcus (n = 20), and Enterococcus (n = 17). Differences were noted in 
the distribution of particular genera between the CB and the rivers. 13/17 (76%) 
Enterococcus isolates were found in the rivers versus 4/17 (24%) in the CB.  This 
difference was statistically significant (p = .001). Differences in distribution of all other 
genera were not significant (p > 0.05). All Staphylococci were resistant to 
chloramphenicol; overall clindamycin resistance was 55%. However, resistance to 
clindamycin was significantly higher in the Bay (71%, 10/14) versus the rivers (17%, 
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1/6) (p = 0.026). All Lactococcus isolates were resistant to rifampin, linezolid, and 
ciprofloxacin; 90% (9/10) were resistant to chloramphenicol, and 80% (8/10) were 
resistant to trimethoprim-sulfamethoxazole. All Enterococci were resistant to linezolid 
with MICs ranging from 6 µg/ml to > 256 µg/ml. 
Discussion. The differential distribution of some Gram-positive organisms 
recovered in this study may be related to the proximity of industrial agriculture to the 
sampling site. Although some of the antimicrobial resistance was expected, the amount of 
chloramphenicol and linezolid resistance was not. This raises some interesting questions 
regarding the origin of this resistance and the specific mechanism(s) responsible. A more 
comprehensive survey over a longer period of time and characterization of the specific 
determinant(s) of resistance are needed to further examine these questions. 
 
Background  
Bacteria may be separated using many classification schema, but perhaps the most 
common and fundamental of these is the Gram stain reaction. The Gram stain, developed 
in 1884 by Christian Gram, divides bacteria into Gram-positive or Gram-negative on the 
basis of the structure of their cell wall (Silhavy, 2010). Gram-positive bacteria retain the 
crystal violet/iodine complexes that form during staining, resisting decolorization and 
resulting in a deep purple appearance under magnification. Gram-negative bacteria do not 
retain the primary stain, decolorize easily, and take up the counterstain, safranin, resulting 
in a pink or reddish color when viewed through a microscope. The cell wall of Gram-
positive bacteria contains a much thicker peptidoglycan layer than what is found in their 
complement, Gram-negative organisms. Additionally, Gram-positive bacteria possess 
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teichoic and lipoteichoic acids in their cell walls, and do not have an outer membrane. All 
of this is in contrast with Gram-negative bacteria, which possess lipopolysaccharides and 
an outer cell membrane (Silhavy, 2010). These differences in structure often play a role 
in pathogenic potential as well as susceptibility to antibiotics. (Jeljaszewicz, 2000). 
Several genera of Gram-positive bacteria are of critical clinical importance 
representing a significant cause of both hospital and community acquired infections. 
Staphylococcus, Streptococcus, and Enterococcus are three of the most significant genera 
of Gram + cocci in human disease, resulting in a range of ailments from respiratory and 
skin/soft tissue infections, to meningitis and septicemia (Jeljaszewicz, 2000; Rice, 2006). 
All three of these genera also contain organisms that represent normal flora in humans, 
which can sometimes complicate diagnoses. Gram-positive bacilli tend to be less 
common in cases of human infection, although infection with certain species of Bacillus 
(anthracis, cereus) and Clostridium (tetani, perfringens, difficile, botulinum) can result in 
significant morbidity and mortality. Bacillus and Clostridium species are commonly 
found in the environment, and are generally opportunistic. Other Gram-positive bacilli, 
such as Lactobacillus, are found as commensal flora in the human body, and are taken as 
probiotics to maintain healthy colonization. What is important to remember is, while 
many Gram-positive bacteria are important causes of infection and even mortality, they 
also exist as critical elements of our normal flora, and the correct balance must be 
maintained to ensure optimal health. 
The emergence of antibiotic resistance in Gram-positive bacteria has greatly 
complicated treatment. Methicillin-resistant, and now even vancomycin-resistant, 
Staphylococcus aureus infections are becoming more frequent, and acquired vancomycin 
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resistance in Enterococcus species continues to spread. As of 2009, it was estimated that 
15-30% of Streptococcus pneumoniae isolates were resistant to three or more classes of 
antibiotics, classifying them as multi-drug resistant pathogens (Lynch, 2009). These 
antibiotic resistant infections pose a significant hurdle to effective healthcare, increase 
patient mortality, and raise the burden of cost on both the healthcare system and the 
patient.  
The environment is an often-overlooked, yet critical component to the study of 
antibiotic resistance and its spread. Routinely, the primary bacteria-focused 
environmental testing conducted related to water quality. This typically only screens for 
certain species, tells us nothing regarding the antibiotic resistance that may be carried in 
the indicator organisms detected, and leaves a multitude of other ecological niches 
unexamined. Often, when further environmental sampling is conducted, Gram-negative, 
enteric organisms are the focus, as these are common, important pathogens of humans 
and can indicate points of fecal contamination. Gram-positive bacteria in the environment 
warrant equal study since Enterococcus species may also be present as an indicator of 
fecal contamination and drug resistance. Underscoring the importance of studying both 
Gram-negative and Gram-positive organisms and their resistance patterns in the 
environment is the widespread Class 1 integron-mediated resistance genes in Gram-
positive bacteria found in poultry litter, when previously these genes were thought to 
exist primarily in Gram-negative hosts with only rare spread to Gram-positive organisms 
(Nandi, 2004). Gram-positive bacteria possessing resistance genes have been previously 
documented in coastal and/or polluted waters. These findings are not geographically 
restricted, with resistant isolates identified in Mexico (Curiel-Ayala, 2012), Tunisia (Said, 
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2015), Brazil (Basso, 2014), Serbia (Veljovic, 2013), and California (Dorsey, 2010; 
Goodwin, 2012). The Chesapeake Bay and upper watershed regions of Maryland are 
subject to runoff from many sources, such as agriculture, animal farming, and wastewater 
of human origin. Despite this, very little work has been done to identify the prevalent 
bacterial species in these waters and the resistance profiles they possess. Previous 
research from our group has shown unique antibiotic resistance profiles in Gram-negative 
bacteria residing in the waters of the Chesapeake Bay and Upper Watershed. Here, we 
sought to identify and characterize Gram-positive bacteria and antibiotic resistance in 
isolates recovered from ten sites along the Chesapeake Bay and rivers in the upper 
watershed. This work represents the completion of a pilot study begun in 2012 designed 
to characterize the variety of bacteria in the Chesapeake Bay and upper watershed, 
determine the relative distribution of each genus and species recovered as well as the 
antibiotic susceptibility and resistance in these populations. 
 
Materials and Methods:  
 
Water sampling. Water samples were collected in the summer of 2012. Sampling 
sites were selected based proximity to human interaction, industrialized agriculture, 
sewage run-off, and historical sites previously sampled 40 years ago as a comparator 
(Saylor, 1975). A total of 10 sites were selected: 5 in the Chesapeake Bay, and 5 in 
freshwater rivers and creeks in the upper watershed. Chesapeake Bay sites (sites 1 
through 5) included Northpoint State Park, the Inner Harbor of Baltimore, Eastern Neck 
Wildlife Preserve, Sandy Point State Park, and Gunpowder Falls State Park, respectively. 
Freshwater rivers and creeks (sites 6 through 10) included the Monocacy River, Catoctin 
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Creek, the Potomac River at Shepherdstown, the Shenandoah River, and the Potomac 
River at Point of Rocks, respectively. Figure 1 shows the exact location of each of these 
sampling locations. A total volume of three liters of subsurface water (~ 1 foot below the 
surface) was collected from each site into sterile, screw-cap glass bottles, which were 
transported to the lab on ice as rapidly as possible. Gloves were worn during collection to 
protect water samples from contaminating normal flora. 
Bacterial identification. A minimum of 150 mls were taken from each water 
sample and vacuum filtered through a sterile, 0.2 µm filter. Following filtration, each 
filter was sectioned using aseptic technique and placed into tubes of Luria Bertani (LB) 
or trypticase-soy broth (Becton Dickinson, Sparks, Maryland). All tubes were 
subsequently incubated for 24 hours at 37ºC and observed for turbidity, which was 
attributed to bacterial growth. Turbid broths were sub-cultured onto trypticase-soy agar 
containing 5% sheep’s blood (SBA, Becton Dickinson) and MacConkey agar (Becton 
Dickinson). All plates were incubated at 37ºC for 24 hours. Distinct bacterial colonies 
observed post-incubation were sub-cultured onto an assortment of microbiological media 
for further isolation and characterization (SBA, MacConkey, Hektoen, xylose-lysine-
deoxycholate [XLD], and Columbia agar w/ colistin and nalidixic acid [CNA]) and 
incubated another 24 hours at 37ºC. Isolated, pure colonies from selective media were 
Gram stained and those that were Gram-positive were subjected to further 
characterization and identification to the species level. For all isolates, specific 
biochemical tests were performed (catalase and coagulase) to aid in identification to the 
genus level. Identification to the species-level was performed using Matrix-Assisted 
Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-Tof MS) 
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analysis. MALDI-Tof MS-based identifications were compared to Gram stain, colony 
morphology, and biochemical test results to ensure agreement; discrepant results were 
repeated. 
Antibiotic susceptibility testing. Once each Gram-positive organism had been 
identified to the genus/species level, antibiotic susceptibility testing was performed using 
E-tests (Biomerieux, France) with interpretations assigned (susceptible, intermediate, or 
resistant) per current guidelines from the Clinical and Laboratory Standards Institute 
(CLSI, 2016). For all assays, a 0.5 McFarland standard bacterial suspension was prepared 
for each isolate or control organism in MH broth, with bacterial lawns plated onto either 
80mm or 150mm MH agar plates. Sterile, disposable forceps were used to aseptically 
transfer E-test strips onto each inoculated agar plate (80 mm plates up to 2 E-tests 
placed;150 mm plates, up to 6 E-tests placed). Following E-test placement, all plates 
were incubated at 37ºC for 24 hours, or until a confluent lawn of growth was apparent. 
The minimum inhibitory concentration (MIC) for each antibiotic was determined by 
noting the point at which the no-growth ellipse intersected each E-test strip.  
 
Results  
Isolate identification. A total of 142 unique Gram-positive isolates were recovered 
from all sites considered together. These isolates represented 4 primary genera: Bacillus 
(n = 95), Lactococcus (n = 10), Staphylococcus (n = 20), and Enterococcus (n = 17). 
Isolates fitting criteria for presumptive Bacillus species classification (characteristic 
colony and Gram stain morphology, positive catalase test) were not further analyzed for 
the purposes of this study. One Gram-positive bacillus not fitting the criteria for 
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presumptive Bacillus species classification was obtained, and was determined to be 
Lysinibacillus fusiformis. This isolate was also not further analyzed for the purposes of 
this study. In total, 47 Gram + cocci were analyzed. Of these, 43% were Staphylococcus 
species, 21% were Lactococcus species, and 36% were Enterococcus species. Only one 
species within the genus Lactococcus was isolated: Lactococcus garviae (n=10). Five 
species within the genera Staphylococcus were isolated: S. caprae (n=1), S. lugdunensis 
(n=2), S. warneri (n=2), S. epidermidis (n=9) and S. haemolyticus (n=6). Three species 
within the genera Enterococcus were isolated: E. faecalis (n=6), E. casseliflavus (n=10), 
and E. mundtii (n=1).   
Stratified by location, 26 isolates (55%) were recovered from the Chesapeake Bay 
and 21 isolates (45%) were recovered from the upper watershed. Table 1 denotes 
bacterial species isolated from each of the ten sites, subdivided by region. No statistical 
significance was observed in the total number of bacterial isolates recovered from the 
Chesapeake Bay versus the upper watershed. Bacterial species isolated varied between 
the Chesapeake region and the watershed, with the exception of the Lactococcus isolates, 
of which only one species was recovered. In the Chesapeake Bay alone, 54% (14/26) of 
the bacteria recovered were Staphylococcus species, 31% (8/26) were Lactococcus 
species, and 15% (4/26) were Enterococcus species. In the upper watershed alone, 29% 
(6/21) of the bacteria isolated were Staphylococcus species, 9% (2/21) were Lactococcus 
species, and 62% (13/21) were Enterococcus species. The greatest variety of 
Staphylococcus species was isolated from the Chesapeake Bay: all five species were 
found in the Chesapeake Bay, while only two species were found in the watershed. In the 
Chesapeake Bay, S. haemolyticus represented the majority of species found, at 43%. 
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Other species isolated in order of abundance were S. epidermidis (29%), S. lugdunensis 
(14%), S. warneri and S. caprae (7% each). Staphylococcus isolates from the watershed 
were predominantly S. epidermidis (83%, 5/6), with only one sample yielding a different 
species, S. warneri. Variation existed in the Enterococcus isolates as well, with most 
species variety noted in the upper watershed region. Of the 4 Chesapeake Bay samples 
yielding Enterococcus, 50% were E. casseliflavus and 50% were E. faecalis. In the 
watershed samples, 61% (8/13) were E. casseliflavus, 31% (4/13) were E. faecalis, and 
8% (1/13) were E. mundtii. 
There was no significant difference between the overall number of 
Staphylococcus or Lactococcus species isolated in all sites considered together or 
stratified by either the Chesapeake region (p=0.368, p=0.342, respectively) or upper 
watershed (p=0.271, p=0.226), respectively. No significant difference existed between 
the number of Enteroccocus species recovered from all sites considered together or those 
isolated from the Chesapeake Bay sites specifically (p=0.057); however, the number of 
Enterococcus species recovered from the upper watershed versus all other sites was 
statistically significant (p=0.046).  
When distribution of organisms was compared and stratified by the Chesapeake 
Bay versus the upper watershed, no statistical difference was noted for Staphylococcus 
and Lactococcus species (p>0.05). However, the difference in distribution of 
Enterococcus species was statistically different between the Bay and watershed (p 
=0.001).  
Antibiotic susceptibility testing. Relevant breakpoints for determination of the 
minimum inhibitory concentrations for each isolate were obtained from CLSI, and are 
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shown in Table 2. It is important to note that CLSI currently does not include 
Lactococcus species in their published breakpoint guidelines, so breakpoints for 
Enterococcus species were applied to these closely related organisms.  
Antibiotic susceptibilities for all Staphylococcus isolates are shown in Table 3. 
All Staphylococcus species recovered showed intermediate resistance to 
chloramphenicol, and 55% (11/20) were intermediate or completely resistant to 
clindamycin. Interestingly, resistance to clindamycin was much more pronounced in the 
Chesapeake Bay, (71% 10/14) versus the upper watershed (17%, 1/6). This difference 
was statistically significant (p=0.026). Only two Staphylococcus isolates were resistant to 
daptomycin, both S. epidermidis. None of the Staphylococcus species recovered were 
resistant to all three of these drugs. All Staphylococcus isolates were susceptible to all 
other antibiotics tested: ciprofloxacin, linezolid, rifampin, tetracycline, trimethoprim-
sulfamethoxazole, and vancomycin. 
Of the Enterococcus species recovered, all were susceptible to daptomycin as 
shown in Table 4. Eight isolates showed intermediate resistance to vancomycin (47% 
overall; 50% (2/4) Chesapeake and 46% (6/13) upper watershed with MIC’s of 6ug/mL. 
All vancomycin intermediate Enterococcus species were E. casseliflavus.  All isolates, 
regardless of species demonstrated intermediate resistance (12%, 2/17) or resistance 
(88%, 15/17) to linezolid. However, no significant difference in resistance for these drugs 
was noted between the Chesapeake Bay and the upper watershed (p >0.05).  
By far, the most resistant organisms recovered from the Bay and/or upper 
watershed, were members of the genus, Lactococcus. All antibiotic susceptibilities 
obtained for Lactococcus are shown in Table 5. Lactococcus isolates demonstrated 
21 
intermediate resistance or complete resistance to multiple drugs including; trimethoprim-
sulfamethoxazole (80%, 8/10), chloramphenicol (90%, 9/10), ciprofloxacin (100, 10/10 
isolates), and linezolid (100%, 10/10 isolates). All isolates were resistant to clindamycin 
with MIC’s ranging from 24ug/ml to >256ug/ml, and all were completely resistant to 
rifampin (MIC’s > 32ug/ml). The majority of recovered L. garvieae were susceptible to 
tetracycline; only two L. garvieae isolates tested otherwise, with MIC’s of 16ug/ml and 




Staphylococci are Gram-positive bacteria that are an integral component of 
normal skin and mucous membranes in humans and animals with several species 
possessing pathogenic potential (Becker, 2014). The primary species implicated in human 
infection is S. aureus; however, no S. aureus was isolated from any of the sites sampled 
in this study, in contrast to several other studies conducted on recreational marine waters 
(Goodwin, 2012; Curiel-Ayala, 2012). This could be due to a variety of factors. 
Variations in sampling locations could lead to differences in recovered species. The 
predominance of coagulase-negative Staphylococcus species versus S. aureus recovered 
from the Bay and upper watershed sites sampled in this study may represent point-source 
contamination from agricultural run-off contiguous with selected sites.  Other studies 
have shown an increase in coagulase-negative species versus S. aureus in polluted waters, 
similar to findings in this study (Basso, 2014; Faria, 2009). This suggests that polluted 
22 
waterways may provide a selective advantage for coagulase-negative species, or, perhaps 
more likely, the pollutants themselves may be a source of these bacteria.  
S. lugdunensis has been shown to be the most aggressive of the coagulase-
negative Staphylococcus, with pathogenic potential beyond simply opportunism in 
compromised hosts, while S. epidermidis and S. haemolyticus are two of the most 
common, opportunistic species (Becker, 2014). It is reasonable to suspect that the 
presence of Staphylococcus species in the waters sampled is due to contamination from 
people, animals, and runoff, as water is not a characteristic ecological niche for this 
bacterial genus (Becker, 2014). 
One possible reason for the difference in Staphylococcus prevalence between the 
Chesapeake region and the upper watershed region is variation in human interaction with 
the aquatic environments under study. Several Chesapeake Bay sites are adjacent to 
known recreational waters, whereas the rivers in the upper watershed region are less 
likely subject to human interaction, and more subject to use by natural wildlife. 
Additionally, if runoff or pollution is the source of Staphylococcus, then proximity of the 
runoff to these waterways might explain the differences in prevalence noted between 
regions. 
The most striking finding from susceptibility testing on the recovered 
Staphylococcus isolates was resistance to chloramphenicol and clindamycin. Previous 
research involving polluted waters has shown varying levels of resistance to both 
chloramphenicol and clindamycin (Kessie, 1998; Basso, 2014). Kessie et al (1998) found 
that chloramphenicol resistance in Staphylococcus from Morocco was plasmid-mediated, 
presenting a reservoir of transferable antibiotic resistance genes within the environment. 
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It was concluded that the presence of chloramphenicol and clindamycin resistance in 
waterways in both Morocco and Brazil was primarily caused by human and agricultural 
runoff. While geographically distant and distinct, this is relevant to the Chesapeake Bay 
and upper watershed because these waterways are also subjected to varying levels of both 
human and animal run-off.  
Enterococci are common, Gram-positive, commensal bacteria in the GI tract of 
both humans and animals, but have been known to cause infections in humans, including 
endocarditis, sepsis, and urinary tract infections. Species of Enterococcus are one of the 
most common infective agents implicated in nosocomial infections, second only to 
Staphylococcus species (Liu, 2014). Enterococcus species are often utilized as indicators 
of fecal contamination in the environment. Due to runoff of human waste, use of animal 
waste as fertilizers, and runoff from farming operations, it is no surprise that isolation of 
Enterococci from water and soil is not a rare occurrence. This is of concern, as, not only 
are certain species of Enterococci notable human pathogens (primarily E. faecium and E. 
faecalis), but antibiotic resistance is quickly becoming a major problem and the potential 
exists for the spread of resistance in such an environmental reservoir. In the current study, 
recovery of an inordinate number of Enterococci from sites predominantly in the upper 
watershed (sites 5-7, 9, and 10) may be the result of agricultural waste runoff, as our 
sampling locations were selected, in part, for their proximity to industrial agriculture. 
Enterococci are common fecal bacteria for many animals, including poultry, which 
comprise a great deal of the animal farming operations in Maryland. Additionally, it is 
very likely that more wildlife frequent the upper watershed rivers and creeks than the 
Chesapeake Bay area; therefore, a portion of the difference in Enterococcus prevalence 
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may be due to the natural use of these waterways by the animals inhabiting the region. 
Further studies are needed to definitively confirm these possibilities and their specific 
contributions to the results we have seen. 
While no vancomycin resistance was found in species of Enterococcus with 
primary clinical relevance, the existence of intermediate resistance to this drug in other, 
typically non-pathogenic species was noted. Decreased vancomycin susceptibility was 
only shown in E. casseliflavus species. This is not surprising, since E. casseliflavus is one 
species of Enterococcus that carries low-level, intrinsic resistance to vancomycin through 
the chromosomal VanC gene (Berenger, 2015; Gholizadeh, 2000; Narciso-Shiavon, 
2015). Another low-level vancomycin resistance mechanism, the VanE gene cluster, is 
extremely similar in sequence and characteristics to the VanC gene cluster. VanE had 
been previously found in E. faecalis and was hypothesized to have originated from 
acquisition of the VanC gene cluster from other species of Enterococci (Gholizadeh, 
2000). Since E. faecalis isolates were recovered from some of the same sites as E. 
casseliflavus, it may be reasonable to speculate that E. faecalis could have acquired such 
a resistance determinant. The VanE gene cluster, luckily, is not accompanied by the most 
severe of consequences, as antibiotic resistance goes. Though it confers low-level 
resistance to vancomycin, susceptibility to teicoplanin remains intact, and infections 
should, theoretically, continue to be treatable (Gholizadeh, 2000). That said, no level of 
antibiotic resistance should be taken lightly. In addition to the concern that antibiotic 
resistance could be spread through environmental exposure, E. casseliflavus, while not 
typically a human pathogen, has been shown to cause occasional human infections 
(Berenger, 2015; Narciso-Shiavon, 2015). This gives its resistance profile in the 
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environment relevance on its own. The same may be said for E. mundtii, which has been 
documented in cases of human infection as well (Higashide, 2005). 
Lactococcus garvieae is a lactic acid bacterium, formerly classified as an 
Enterococcus, or a Lancefield group N Streptococcus (Elliott, 1996; Collins, 1983). This 
Gram-positive, lactic acid bacteria is commonly found on fish and other animals, so it is 
not surprising to have recovered it from our water samples. While having fairly little 
relevance to human pathology because of the rarity of L. garvieae infection, occasional 
cases of endocarditis, peritonitis, and sepsis have been documented (Mitra, 2015, Russo 
2012). Increasing aquaculture activities and fish farming operations will bring humans 
and L. garvieae into more frequent contact, potentially leading to additional infections in 
the future (Russo, 2012; Mitra, 2015).  
L. garvieae is widely known to be resistant to clindamycin, so this result was 
expected. Clindamycin resistance is so widespread that this characteristic has been 
suggested as a potential identification mechanism to distinguish L. garvieae from L. 
lactis. (Elliott, 1996; Mitra, 2015). Other studies, however, have shown that clindamycin 
resistance is not always a distinguishing factor (Walther, 2008). A literature search 
yielded very little information on extensive resistance in L. garvieae, save for a study by 
Raissy et al (2006) that showed L. garvieae harboring multiple resistance genes. Some 
studies have shown resistance to rifampin (Russo, 2012; Aubin, 2011). Chloramphenicol 
resistance has not been widely documented, with several studies showing complete 
susceptibility, and ciprofloxacin resistance has been rare (Raissy, 2006; Elliott, 2006). 
Resistance to clindamycin, chloramphenicol, and ciprofloxacin together was recently 
seen in a patient presenting with L. garvieae meningitis (Tandel, 2015).  
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In both Lactococcus and Enterococcus species, resistance to linezolid was 
observed in all isolates recovered, a finding which was completely unexpected since 
widespread resistance to this drug has not been seen to date.  In attempting to explain this 
resistance, there are several possible explanations to consider. The ascidian, Synoicum 
pulmonaria has been shown to produce compounds known as ‘synoxazolidinones’ which 
have antimicrobial properties in vitro (Trepos, 2014). These compounds are structurally 
quite similar to linezolid, an oxazolidinone antibiotic. While this was observed off the 
coast of Norway, it is not unreasonable to anticipate that other species of aquatic life may 
produce similar compounds that we simply have not observed yet. It could be that the 
natural antimicrobials produced by certain species of aquatic life are mimicking the 
mechanism of linezolid, resulting in selective pressure on these bacteria to evolve 
resistance mechanisms to survive. Additionally, there are several genes carried on 
plasmids known to confer resistance to linezolid, including cfr and OptrA. These 
plasmids may be readily transferred between bacteria, which may explain the widespread 
resistance to linezolid observed in this study. This also may explain the resistance to 
chloramphenicol, since resistance to phenicols and oxazolidinones are conferred together 
on the cfr gene. No previous studies have observed linezolid resistance in L. garvieae, so 
recovery of resistant L. garvieae isolates from the Chesapeake Bay and upper watershed 
may be a novel occurrence. Resistance in Enterococcus has, however, been previously 
documented, primarily in clinical isolates with previous drug exposure and/or possession 
of a plasmid conferring resistance (Wang, 2015). 
Determination of the genetic mechanism behind the observed antibiotic resistance 
in the Chesapeake Bay and upper watershed isolates has not yet been conducted, and 
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presents another interesting dimension of research into these isolates. One may 
hypothesize that antibiotic resistance in these waterways presents a potential reservoir of 
genetic resistance determinants that may be transferred to other bacterial species. By 
investigating the genetic basis for resistance in these bacteria, we could gain valuable 
insight as to potential sources of bacterial contamination and get a much better grasp on 
the risk of further dissemination of observed resistance. 
Future studies. This study was designed as a pilot survey of select sites in the 
Chesapeake Bay and upper watershed as a means to establish a baseline for bacterial 
diversity, distribution and antibiotic resistance. It is important to note, however, that only 
5 sites in the Chesapeake Bay and 5 sites in the upper watershed were sampled. Sampling 
of additional sites would provide insight into bacterial prevalence across a greater 
geographic area. Furthermore, samples could be collected throughout the year to paint a 
more comprehensive picture of month-to-month and season-to-season variation in 
microbial diversity, distribution and antibiotic resistance.  More frequent and wide-
reaching sampling may also shed light on how changes in weather, animal migration, and 
human recreation impact the microbiome and resistome of the Chesapeake Bay and upper 
watershed.  
 Characterization of the genetic determinants of antimicrobial resistance, 
(chromosomal or plasmid-mediated, the genes affected, specific mutations involved), 
could elucidate the dynamic nature of bacterial interaction in the environment. As a 
result, predictive models may be possible to help in understanding the emergence and 















Figure 1: Sampling Sites in the Chesapeake Bay and Upper Watershed 




Antimicrobial Activity of a Wide Variety of Essential Oils against Multi-drug 





Background. Essential oils (EOs) have been used since antiquity for treatment of 
infections. Due to emerging antibiotic resistance, new drugs are needed. Determining the 
spectrum of activity of various EO’s against an array of bacteria with elucidation of the 
mechanism of action mediated by principle components could provide the means to 
identify new drug targets. 
Methods. EO’s (n = 88) were selected and grouped according to primary 
constituent(s) (e.g. aldehyde, phenol, terpenoid, alcohol, etc.). Six multi-drug resistant 
(MDR) isolates were used for all assays: Klebsiella pneumoniae (2 strains), Enterobacter 
cloacae, Salmonella enterica, Acinetobacter baumannii and methicillin-resistant 
Staphylococcus aureus (MRSA). Testing was done by disk diffusion using 10µl of EO 
per MH agar plate. All plates were incubated for 24 hours at 37◦C and zones of inhibition 
measured in mm. Susceptibility testing of currently used antibiotics was performed using 
the standard Kirby-Bauer method; susceptible/resistant zone diameters were used as 
comparators for EO-mediated zones of inhibition, for which no interpretive criteria exist.   
Results. Of all the EO’s tested, the most potent against both Gram + and Gram – 
bacteria were those whose primary constituent consisted of an aldehyde. Interestingly, 
these were more potent than phenolic or alcohol-based EO’s. Overall zones on MRSA for 
aldehyde containing EOs considered together ranged from 13.5mm to 80mm (mean = 
31mm), excluding vanilla, which had no activity (6mm). Standard antibiotic zones for 
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MRSA ranged from no activity (6mm) to 22mm (mean = 12mm), with the highest 
activity from rifampin (22mm). Overall zones for aldehyde containing EO’s with multi-
drug resistant Gram-negative isolates ranged from 6mm to 26mm (mean = 12mm). 
Standard antibiotic zones for multi-drug resistant Gram-negative isolates ranged from no 
activity (6mm) to 21mm (mean = 11), with the overall highest activity from imipenem 
(range 6mm – 21mm; mean = 16mm). Zone diameters for the most potent aldehyde-
containing EO’s were consistent with susceptible zones for many of the standard 
antibiotics for Gram-negative bacteria, and often more inhibitory than antibiotics for 
Gram-positive bacteria. Differences were noted in activity between Gram-positive/Gram-
negative bacteria and between primary constituents. For example, MRSA was completely 
inhibited by cilantro, which contains 21% decenal, whereas for the Gram-negative 
organisms, little to no inhibition was seen. Cassia was consistently more potent against 
all organisms tested (range 15-27 mm) than cinnamon bark (range 19-23 mm) with the 
chief difference between the two being either the trans- or cis-configuration of 
cinnamaldehyde, respectively.   
Discussion. This study revealed some unexpected findings: 1) aldehyde-
containing EOs demonstrated the most potent activity against all organisms tested, 2) 
phenolic-based EOs were less potent in comparison but demonstrated more activity in 
general than alcohol- or terpene-based EO’s, 3) importantly, some aldehyde-mediated 
activity was species-specific suggesting a potential mechanism of action which should be 
investigated further, 4) elucidation of the mechanism underlying this differential activity 





Essential oils (EOs) have been used since antiquity for the treatment of various 
maladies and infections. These oils are aromatic, secondary metabolite extracts from 
plant components, such as stems, leaves, flowers, and bark. EOs have been utilized in 
medicine and in food, as well as in perfumes and cosmetics. It is known that many of the 
chemicals present in EOs have antimicrobial properties, and may be used by plants for 
defense (Hyldgaard, 2012). 
Previous studies have demonstrated the activity of a limited number of EOs 
against common human pathogens (Reichling, 2009). For instance, in a study by 
Oussalah and colleagues (2007) their results demonstrated that EOs possess broad-
spectrum antibacterial properties against both Gram-negative and Gram-positive bacteria. 
Other investigators have shown EO-mediated activity against a wide variety of clinically 
relevant bacteria, including but not limited to: Helicobacter pylori (Bergonzelli, 2003), 
Mycoplasma species (Harkenthal, 2000; Furneri, 2006), Streptococcus pneumoniae 
(Inouye, 2001), Staphylococcus aureus (Reichling, 2002), and Escherichia coli (Cox, 
1998). EOs are also posited to have effects against parasites, viruses, and fungi 
(Hyldgaard, 2012; George, 2009; Schnitzler, 2011). EO activity has also been shown 
against enveloped viruses, such as Herpes Simplex Virus, but not viruses lacking an 
envelope (Schnitzler, 2007). Antifungal activity has also been demonstrated against 
various species (Hammer, 2004). Previous research in the Parrish lab has shown very 
potent antifungal effects of an EO derived from orange peels. This EO exhibited very 
strong inhibition of Pseudogymnoascus destructans, the causative agent of White-Nose 
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Syndrome in bats, with lesser inhibition of a variety of other environmental fungal and 
bacterial organisms (Boire, 2016).  
Traditional medicine has utilized medicinal plants in the treatment of disease for 
centuries. In fact, many drugs that we use today have been derived from plants and/or 
other natural sources (Lopez-Romero, 2015). For example, daptomycin is a natural 
product, and cefepime, doripenem, tigecycline, azithromycin, and aztreonam, to name 
only a few, are all naturally derived (Newman, 2007). Unfortunately, increasing 
resistance to many commonly used antibiotics, such as ß-lactams, and even last resort 
antibiotics, such as vancomycin and linezolid, is complicating patient care and increasing 
morbidity and mortality around the world. Antibiotic development, while not entirely 
nonexistent, has slowed considerably and cannot keep up with the increases in resistance 
that we now see. Due to this emerging antibiotic resistance and the lack of focused 
research and development for new drugs it is critical to identify novel antimicrobials and 
targets.  
Determining the spectrum of activity of various essential oils against an array of 
bacteria with elucidation of the mechanism of action mediated by principle components 
could provide the means to identify new drug targets. In the current study, we 
investigated the activity of a large number of essential oils against multi-drug resistant 
Gram-positive and Gram-negative bacteria of clinical importance. To the best of our 
knowledge, this study represents the first comprehensive investigation of so many 
essential oils against some of the most antibiotic resistant bacteria currently encountered 
in clinical medicine today. 
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Materials and Methods:  
Classification of essential oils. EO’s (n = 88), provided by dōTERRA 
International, were grouped according to their primary constituent(s) as determined by 
mass spectrometry. Table 1 shows the various classes of EOs and the number tested in 
each category. Twenty EOs were difficult to classify based on primary constituent, 
because these oils were designed to be complex blends. These oil blends, listed in Table 
2, comprised a separate group for testing and analysis. Solubility and integration of EOs 
into solid media is discussed on page 40. 
Kirby-Bauer testing with standard antibiotics. Susceptibility testing of standard 
antibiotics was performed on all MDR isolates, as well as control strains (S. aureus 
ATCC 25923, E. coli ATCC 35218) using the Kirby-Bauer method. All standard 
antibiotics were obtained from Becton Dickinson and included: gentamicin (10µg), 
ciprofloxacin (5µg), chloramphenicol (30µg), colistin (10µg), tetracycline (30µg), 
ceftazidime (30µg), ceftriaxone (30µg), imipenem (10µg), rifampin (5µg), erythromycin 
(15µg), and trimethoprim-sulfamethoxazole (23.75/1.25µg). MH broth and prepared agar 
was permitted to warm to room temperature prior to use. A 0.5 McFarland standard was 
prepared for each isolate/control and a lawn-plated on 150mm MH (Becton Dickinson) 
agar plates. Sterile, disposable forceps were used to aseptically transfer antibiotic disks 
onto the agar surface. Plates were permitted to sit for approximately ten minutes to allow 
the disks to bond to the agar prior to their inversion and incubation at 37◦C for 24 hours. 
Following incubation, zones of inhibition (ZOI) were measured and interpreted according 
to current CLSI guidelines (CLSI, 2016). Susceptible or resistant zone diameters were 
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used as comparators for EO-mediated ZOI, for which no interpretive criteria currently 
exist.  
Disk diffusion testing of essential oils. Seven clinically derived, MDR bacterial 
isolates were used for all assays: Klebsiella pneumoniae (2 strains), Enterobacter 
cloacae, Salmonella enterica (NDM-1 +), Acinetobacter baumannii, Pseudomonas 
aeruginosa, and Methicillin-Resistant Staphylococcus aureus. For all organisms, a 0.5 
McFarland standard was prepared in MH broth, and bacterial lawns were plated onto 
80mm MH (Becton Dickinson) agar plates using sterile cotton swabs. Sterile, disposable 
forceps were used to aseptically transfer one sterile, paper disk onto the center of each 
agar plate. Ten microliters of each EO or dimethyl sulfoxide (DMSO), used as a control, 
was pipetted onto individual paper disks, and allowed to sit for approximately ten 
minutes before being placed in an incubator at 37◦C for 24 hours. Following incubation, 
ZOI were measured in millimeters.  
EO inhibition at varying temperatures. All procedures for the preparation and 
inoculation of experimental plates remained consistent for this portion of testing. A 
subset of EO’s were selected based on their variety of chemical classifications and 
varying activity against Enterobacter cloacae and Salmonella enterica. EO’s tested 
included cilantro, citronella, oregano, cassia, frankincense, wintergreen, and cinnamon 
bark. Once the EO was permitted to soak into the disk, the plates were then subjected to 
incubation at varying temperatures. One set of plates was incubated at 37◦C for 18-24 
hours as per standard procedure. The other set of plates was incubated at 4◦C for 24 
hours, then incubated at 37◦C for an additional 18-24 hours. Upon completion of 
incubation, the ZOI were measured in mm and compared to examine temperature 
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dependent changes in bacterial growth rate or temperature dependent alterations in the 
diffusion of the oil throughout the agar medium. 
 Determination of percent inhibition as a surrogate for minimum inhibitory 
concentration. Percent inhibition was determined for the ten most inhibitory oils for 4 
bacterial species: MRSA, E. cloacae, S. enterica (NDM-1 +) and P. aeruginosa. These 
studies were conducted by incorporating each EO or dilution in DMSO directly into 
individual agar plates. This effect required determination of miscibility and stability in 
MH agar. In order to prevent the oil from separating from the media prior to 
solidification, 0.5% v/v Tween 80 was added to MH agar (Becton Dickinson) at 55◦C, 
then cooled to 48◦C for addition of the oil (10µl per plate). Control plates were prepared 
by adding only Tween 80, by adding Tween 80 and 10µl DMSO per plate, or by adding 
only 10µl DMSO per plate. Experimental miscibility MH plates were also crafted under 
the same conditions as listed for Tween 80; however, only DMSO (20µl) was added to 
aid in suspension of the oil within the liquid media.  
Essential oil preparation: For each EO being tested, a two-fold serial dilution 
series was created in DMSO, out to 1:16 or 1:32, depending on undiluted oil potency. EO 
concentrations started at 100% (1X - undiluted), and decreased as follows: 50% (1:2), 
25% (1:4), 12.5% (1:8), 6.25% (1:16), and in some cases 3.125% (1:32).  
Agar dilution preparation: Once an effective method of incorporating EOs into 
MH agar was determined, it was then utilized as the standard method for agar dilution 
testing. Ten microliters of each EO dilution was mixed 1:1 with DMSO (10µl) and added 
to liquid MH agar at 50ºC. The media was mixed well using a magnetic stir bar, and 
individual plates were poured separately for each oil concentration to be tested. For 
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control plates, 20µl of DMSO was added in place of the essential oil/DMSO mixture. 
Once the plates were cooled and solidified, they were either utilized immediately or 
stored at 4ºC. Plates containing EOs with light sensitive primary constituents were stored 
wrapped in foil to block out the light. To avoid potential EO degradation, plates were 
made no more than three days prior to use.  
Plate inoculation: A standard 0.5 McFarland bacterial suspension was created for 
each organism to be tested, and 0.5µl was diluted into 5ml MH broth to create a 
suspension of approximately 1x104 colony forming units per ml (CFU/ml); 25µl of the 
diluted inoculum was pipetted into the center of each prepared agar dilution plate. 
Subsequently, thirty-to-forty sterile, glass beads (1mm, Sigma-Aldrich, St. Louis, 
Missouri) were added to each plate and used to distribute the inoculum across the surface 
of the agar. The beads were tapped off the agar into CaviCide (Metrex Research, 
Romulus, Michigan) followed by incubation at 37ºC for 24 hours. Following incubation, 
colonies on each plate were counted and percent inhibition on EO plates versus untreated 
controls calculated. All experiments were duplicated for consistency, and repeated a third 
time if there was a discrepancy between the two documented results. 
Synergy testing. Following completion of percent inhibition studies, moderately 
inhibitory concentrations of an aldehyde-containing EO, a phenolic EO, and the 
tropolone EO were combined to screen for additive, antagonistic, and/or synergistic 
effects on bacterial inhibition. Bacterial species selected for this additional screening 
were E. cloacae, S. enterica (NDM-1 +), P. aeruginosa, and MRSA. For S. enterica 
(NDM-1 +) and E. cloacae, the oils and corresponding dilutions chosen for combination 
were cassia 1:2, oregano 1:4, and arborvitae 1X. For P. aeruginosa, the oils chosen for 
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combination included cassia, thyme, and arborvitae, all at 1X, full concentration. For 
MRSA, the oils chosen for combination were cilantro 1:4, oregano 1:4, and arborvitae 
1:8.  
Procedures for preparing the plates remained consistent with the established agar 
dilution protocol, with 10µl of each oil dilution added to the media, to ensure 
comparability with percent inhibition studies. Inoculation and incubation of plates 
proceeded as per the protocol established for percent inhibition denoted previously. 
Assays were performed in duplicate, and colonies on each plate were counted and 
averaged together for comparison against colony counts on control plates to obtain a 
comparable measure of percent inhibition. 
 
Results  
Agar dilution and EO miscibility. While the Tween 80 method was successful in 
integrating the oil into the solid agar, upon inoculation with a 0.5 McFarland standard 
bacterial suspension and incubation at 37ºC for 24 hours, all plates containing Tween 80, 
including the controls, exhibited visible differences in lawn growth. This visible 
difference was neither an enhancement nor reduction in growth, but rather a change in the 
morphology/appearance of growth, to where the growth appeared very wet compared to 
standard growth on MH-only plates. Due to this inconsistency, the Tween 80 method was 
not utilized. An alternate protocol, utilizing only DMSO was attempted. Ten microliters 
of DMSO appeared to be successful in promoting miscibility of the various oils into the 
liquid media prior to solidification; however, this effect was strongest if the 10µl of oil 
and 10µl of DMSO per plate were mixed prior to addition in the liquid agar. The mixture 
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of EO and DMSO were added to the liquid agar after cooling to approximately 50ºC, and 
mixed well into the medium through use of a large magnetic stir bar. The DMSO alone 
did not appear to cause any increase, decrease, or apparent difference in lawn growth 
when inoculated with a 0.5 McFarland standard bacterial suspension and incubated at 
37ºC for 24 hours. Ten and 20 microliters of DMSO per plate was also tested as a control, 
to account for the 10µl added for solubility, and the additional DMSO used as a diluent in 
the EO dilution series. As much as 20µl of DMSO per plate did not appear to affect the 
bacterial growth observed. 
Antibiotic susceptibility of MDR isolates. To have an adequate comparison for 
EO mediated ZOI, antibiotic susceptibilities were performed on the isolates tested. 
This data is shown in Table 3. All isolates were confirmed multi-drug resistant. 
Standard antibiotic zones for MRSA ranged from no activity (6mm) to 22mm (mean = 
12mm), with the highest activity from rifampin (22mm). Standard antibiotic zones for 
MDR Gram-negative isolates ranged from no activity (6mm) to 21mm (mean = 11), with 
the overall highest activity from imipenem (range 6mm – 21mm; mean = 16mm). For P. 
aeruginosa, cassia and cinnamon bark yielded ZOI of 26mm and 22mm, respectively, 
which are consistent with susceptible zones for imipenem (≥ 19mm) and colistin (≥ 
11mm). 
Activity of various single EOs against bacteria of clinical importance. Gram-
positive bacteria were more susceptible to the EO panel than Gram-negative bacteria, 
both in the number of oils that showed activity and in the zone sizes achieved. Table 4 
shows the comprehensive EO screening results for MRSA, Table 5 shows the EO 
screening results for P. aeruginosa, Table 6 shows the EO screening results for A. 
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baumannii, and Table 7 shows the EO screening results for the remaining MDR enteric 
isolates. The EO blends that were tested (Table 2) yielded no remarkable activity in the 
entirety of the group, so this data has not been included, nor further analyzed at this point 
in time. 
Of all the EOs tested, the most potent against both Gram-positive and Gram-
negative were those whose primary constituent consisted of an aldehyde. Interestingly, 
these were more potent than phenolic or alcohol-based EOs. Overall zones for MRSA 
withn aldehyde containing EOs considered together ranged from 13.5mm to 80mm (mean 
= 31mm), excluding vanilla, which had no activity (6mm). Overall zones for aldehyde 
containing EO’s with multi-drug resistant Gram-negative isolates ranged from 6mm to 
26mm (mean = 12mm). Other EO’s that showed lower, but still notable antimicrobial 
activity, included phenolic-based oils, and the single tropolone-based oil. With MRSA, 
the average ZOI for phenolic-based EO’s was 18mm. For A. baumannii and P. 
aeruginosa, the average ZOI with phenolic-based oils was 21mm and 9mm, respectively. 
For the MDR enteric organisms, phenolic-based EOs resulted in an average ZOI of 
16mm. For both Gram-positive and Gram-negative bacteria, aldehyde-, phenol-, and 
tropolone-containing oils all consistently ranked in the top ten most-inhibitory EO’s. 
Table 8 shows the top 10 most inhibitory EOs stratified by organism. 
Differences, however, were noted between Gram-positive/ Gram-negative 
bacteria based on the identity of the primary constituent in the oil. Figure 1 is a barcode 
representation of EO activity against MRSA, P. aeruginosa, and MDR Gram-negative 
organisms considered together with the greatest inhibitory activity indicated to the left of 
each graph and the least active oils at the far right. Blue bars indicate EOs with an 
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aldehyde as the primary constituent; red bars indicate oils with phenolic-based 
compounds; yellow bars indicate EOs containing a tropolone. As shown, aldehyde-
containing EOs, shaded in blue, demonstrated differential effects in MRSA versus the 
Gram-negative organisms tested. With MRSA, the relative placement of aldehyde-
containing EO’s (blue bars) cluster to the far left of the graph, indicating greater 
inhibitory activity. The same cannot be said for any of the Gram-negative organisms 
tested; aldehyde-containing EOs are much more evenly dispersed throughout, indicating 
more variable susceptibility of MDR Gram-negative bacteria to aldehyde-containing 
EOs. When examined more closely, aldehyde activity varied between organisms 
depending on the specific aldehyde in the EO. For example, MRSA was completely 
inhibited by cilantro (80mm), which contains 21% decenal and 10% decanal, whereas for 
the Gram-negative organisms, little to no inhibition was seen. Cassia and cinnamon bark, 
on the other hand, contain cinnamaldehyde, which demonstrated a broader spectrum of 
activity, with very similar inhibition of both Gram-positive (23mm and 19mm, 
respectively) and Gram-negative (23mm and 21mm, respectively) bacteria. However, it is 
interesting to note that cassia was consistently more potent against all organisms tested 
(range 15-27mm, mean = 23mm) than cinnamon bark (range 19-23 mm, mean = 21) with 
the chief difference between the two being either the trans- or cis-configuration of 
cinnamaldehyde, respectively. The single tropolone-containing EO, arborvitae (yellow 
bars), showed only a slight differential effect, inhibiting Gram-positive bacteria slightly 
more effectively than Gram-negative bacteria (20mm vs 16mm, respectively). 
Differential results between Gram-positive and Gram-negative bacteria were not 
observed for phenolic-based essential oils (red bars), as these oils had consistently similar 
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effects, as evidenced by their placement on each graph (19-20mm Gram-negative vs 20-
21mm Gram-positive).  
Temperature experiments. Data pertaining to temperature experiments is shown in 
Table 9. When incubated at 4ºC for 24 hours prior to incubation at 37ºC for 24 hours, 
zone sizes for aldehyde-containing essential oils, cassia and cinnamon bark, increased by 
an average of 10mm. Cassia ZOI increased from a mean of 22mm at 37ºC to 33mm when 
incubated at 4ºC, and cinnamon bark gave similar results with ZOI of 19mm at 37ºC and 
28mm at 4ºC. Zone sizes for other EOs, such as frankincense and wintergreen, remained 
static with ZOI of 6mm (no activity), and ~11mm, respectively. Oregano, a phenolic 
essential oil containing primarily carvacrol, also saw an increase in the zone of inhibition 
when incubated at cooler temperatures, increasing from 16mm at 37ºC to 21mm at 4ºC. 
When incubated at ambient temperature for 24 hours prior to incubation at 37ºC for 24 
hours, zone sizes for all oils remained static compared to standard 37ºC incubation. All 
results were obtained from experiments on the same two Gram-negative bacterial species, 
E. cloacae and S. enterica (NDM-1 +). When temperature studies were conducted with 
cilantro, an EO with no effect on Gram-negative bacteria, zone sizes did not increase, 
even when incubated at 4ºC prior to 37ºC, showing that increased activity at cooler 
temperatures is not universal across the aldehyde-containing EOs. 
Dilution experiments and percent inhibition. Preliminary results of the 
experimental percent inhibition protocol showed a baseline inoculum 7.3 X 104 CFU/ml 
for E. cloacae, 1.4 X 105 CFU/ml for S. enterica, and 9.0 X 104 CFU/ml for MRSA. 
Control MH plates containing 10µl DMSO showed a baseline colony count at 6.8 X 104 
CFU/ml for E. cloacae, 1.4 X 105 CFU/ml for S. enterica, and 1.0 X 105 CFU/ml for 
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MRSA. While exact McFarland standard concentrations varied within the established 
range (0.06-0.10), all inocula were diluted to represent approximately ~5 X 104 CFU/ml. 
Table 10 shows the results of percent inhibition studies for MRSA; Table 11 shows 
results for E. cloacae; Table 12 for S. enterica (NDM-1 +); Table 13 for P. aeruginosa. 
In general, as concentration of the EO within the plate decreased, bacterial inhibition 
decreased, in a relatively linear manner. Only MRSA was completely inhibited by 
multiple EO’s, including cilantro at both 100% and 50% concentrations, oregano at both 
100% and 50% concentrations, and cassia and cinnamon bark at 100% concentration. E. 
cloacae and S. enterica (NDM-1 +) were both only completely inhibited by cassia at 
100% concentration. P. aeruginosa was not completely inhibited by any of the three EOs 
tested, with the highest and only inhibition (53%) occurring with cassia at 100% 
concentration. 
Interestingly, arborvitae against MRSA showed higher activity at 50% and 25% 
concentrations (99% and 91% inhibition, respectively) versus 100% concentration (50% 
inhibition). This did not occur with E. cloacae or S. enterica (NDM-1 +). Similarly, 
clove-mediated inhibition of S. enterica (NDM-1 +) decreased with increasing 
concentration such that 12.5% clove oil was more inhibitory (30% inhibition) than 100% 
(0% inhibition). 
 Synergy testing. Synergy testing results are shown in Tables 14 – 19. Synergy 
was observed for the combination of cassia 1:2, oregano 1:4, and arborvitae 1X against S. 
enterica (NDM-1 +), but not for E. cloacae, against which these combinations became 
antagonistic, with up to 20% less inhibition than the EOs alone (Table 14). Synergy was 
also observed for both MRSA (cilantro 1:4, oregano 1:4, and arborvitae 1:8) and P. 
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aeruginosa (cassia 1X, thyme 1X, and arborvitae 1X) as shown in Tables 15 and 16, 
respectively. All three oils together on both MRSA and P. aeruginosa caused 100% 
inhibition of bacterial growth. Importantly, no single oil was completely inhibitory 
against P. aeruginosa.  Table 17 shows the effect of varying the volume of the same oil 
combinations on E. cloacae and S. enterica (NDM-1 +). A 50% increase in the volume 
(EO volume in the agar increased from 10µl to 15µl) resulted in synergy against both E. 
cloacae and S. enterica (NDM-1 +), with growth of both species completely inhibited, an 
80% increase in activity, on average. A decrease in the volume of EO added from 10µl to 
~7µl resulted in a 7-8% decrease in inhibition, Upon further investigation, as depicted in 
Tables 18 and 19, it was found that by utilizing cassia, oregano, and arborvitae in 100% 
concentration, rather than in diluted form, at only 10µl, both E. cloacae and S. enterica 
(NDM-1 +) could again be completely inhibited.  
 
Discussion 
General discussion. This study revealed several unexpected findings. Phenolic-
based EOs were expected to have broad-spectrum activity since phenolic compounds are 
known to possess antimicrobial activity by way of pore formation in the cell membrane 
which results in loss of the proton motive force, disruption in ATP production, and 
eventual cell death. Because of this non-specific mechanism, phenols typically have 
broad-spectrum activity against a wide array of organisms as illustrated in this study.  
Interestingly, phenolic EOs were less potent than aldehyde-based EOs, but demonstrated 
more activity in general than alcohol- or terpene-based EOs. Activity, both antioxidant 
and antimicrobial, of phenol-containing compounds is also known to vary based on their 
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chemical structure, as well as the amount of phenol present, which explains slight 
differences in the activity of the phenolic EOs: thyme, oregano, and clove. (Parsaeimehr, 
2010)  
In comparison, aldehyde-containing EOs demonstrated the most potent activity 
against all organisms tested with broad-spectrum activity against both Gram-positive and 
Gram-negative bacteria. This activity was most apparent with cassia and cinnamon bark, 
which demonstrated potent activity against all organisms tested including multi-drug 
resistant bacteria of clinical importance. For example, the ZOI for MRSA with cassia and 
cinnamon bark were 23mm and 19mm, respectively, which would be considered a 
susceptible result if these ZOI sizes were observed with standard antibiotics, such as 
trimethoprim-sulfamethoxazole (susceptible ≥ 16mm) and chloramphenicol (susceptible 
≥ 18mm). This MRSA isolate was resistant to chloramphenicol (6mm) and susceptible to 
trimethoprim-sulfamethoxazole (21mm), yet even more susceptible to cassia EO, in the 
context of this antibiotic data. Likewise, E. cloacae and S. enterica (NDM-1 +) were both 
resistant to chloramphenicol with ZOI of 6mm and 12mm (susceptible ≥ 18mm), 
respectively, and gentamicin with ZOI of 6mm for each (susceptible ≥ 15mm). Thus, the 
observed ZOI for both cassia and cinnamon bark for each of these clinical MDR isolates, 
would have been considered susceptible results if measured using the same interpretive 
guidelines as for the standard antibiotics.  
The broad-spectrum activity observed for cassia and cinnamon bark was not 
observed for all aldehyde-containing EOs. Cilantro was, by far, the most potent EO 
tested, offering complete inhibition of MRSA (80mm), yet possessing virtually zero 
activity against any Gram-negative bacteria. The reason for this extreme differential 
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activity is, as yet, unknown. Based on the data gathered in this study, we hypothesize that 
various enzymes within the aldehyde dehydrogenase family may be responsible for the 
metabolism of these aldehyde-containing EOs. Our finding of species-specific activity of 
aldehyde-containing oils would be expected under this hypothesis, as there are many 
aldehyde dehydrogenase enzymes and their specificity for substrates varies.  
Several different mechanisms of antimicrobial aldehyde activity have been 
published. One study discusses the antifungal effects of polygodial through interference 
with and inhibition of ATP-synthase in mitochondria (Castelli, 2005). Many studies, in 
fact, support the connection between aldehydes and mitochondrial effects including 
alterations in membrane potential and decreases in ATPase (Zheng, 2015; Tian, 2012; 
Luo, 2002) Another study showed the effect of trans-cinnamaldehyde on cancer cells via 
interference with growth phase 2 of the cell cycle, resulting in death of the cell (Nagle, 
2012). An aldehyde dehydrogenase mediated effect on the mitochondrial ATP production 
or cell cycle regulation could provide an explanation for the increased activity at slower 
growth rates. 
Elucidation of the mechanism underlying the differential activity observed with 
aldehyde-containing EOs could provide the basis for a new drug target(s) in antibiotic 
resistant bacteria, and warrants further attention. This study is ongoing, and investigation 
of mechanism is planned.  
Variable temperature results. The variable results observed following our 
temperature experiments have several explanations. Firstly, at cooler temperatures, the 
kinetics of the diffusion of each EO throughout the solid media is likely altered. For 
example, the oil likely diffuses slower at cooler temperatures, due to slower molecular 
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movement under low temperature. This could result in a higher concentration of EO 
towards the disk than there would be if the plates were incubated at 37ºC as per normal. It 
is feasible to suggest that this may result in greater bacterial inhibition due to the 
artificially higher concentration around the disk. Differential results would not be 
unexpected if this were the case, as the concentration of the EO may be irrelevant if its 
particular mechanism is ineffective against a certain bacterial isolate. 
Another explanation for the observation of greater bacterial inhibition for specific 
oils at lower temperatures could be the effect of the decreased temperature on bacterial 
growth rate. At cooler temperatures, bacteria naturally grow more slowly. Because of 
this, it may be reasonable to speculate that the compounds in the EO may be able to 
overpower the bacterial growth at cooler temperatures, when, under standard, 37ºC 
conditions, the bacteria grow fast enough that the oil is less effective. For instance, if the 
EO mechanism is based on blocking a certain enzyme-substrate interaction, slowing this 
process down might allow the EO to out-compete the substrate for access to the enzyme’s 
active site. This explanation would likely be highly dependent on the specific mechanism 
and chemical structure of the EO, and so differential results would, again, not be unusual.  
Interpretation of percent inhibition studies. On average, and with few exceptions, 
bacterial inhibition decreased as the concentration of the EO decreased. This was an 
expected outcome. The complete inhibition of MRSA by cilantro and oregano at both 
100% and 50% concentrations is staggering, as is the complete inhibition of S. enterica 
(NDM-1 +) and E. cloacae by cassia at 100% concentration. Considering these are MDR 
clinical isolates that respond to very few standard antibiotics in practical use today, the 
ability to inhibit them completely using a natural EO is both surprising and encouraging. 
52 
On the rare occasion an unusual pattern of inhibition was observed during testing, 
such as with arborvitae (Thuja plicata) in MRSA, this might be explained by a specific 
property of the mechanism of action of the EO. Inhibitory activity is greatest once an 
optimal concentration is achieved; any higher or lower concentration and inhibition 
declines. It may be true that, for MRSA, the optimal concentration of arborvitae is not 
100%. The same could be said for the unusual result obtained with clove oil against S. 
enterica (NDM-1 +). It would seem that the optimal concentration for clove against S. 
enterica (NDM-1 +) is much lower than the optimal concentrations for other EOs against 
the same organism. Again, this comes down to the specific mechanism of action of the 
EO and how it interacts both with the bacteria and the agar medium. Higher 
concentrations of EO will not necessarily translate into increased activity, and the 
arborvitae-MRSA and clove-S. enterica (NDM-1 +) results are an important reminder of 
that. 
Distinct differences were noted between the results of disk diffusion testing and 
percent inhibition studies. For example, while cinnamon bark yielded a ZOI of 22mm on 
P. aeruginosa using disk diffusion, it failed to cause any inhibition when incorporated 
into the agar medium. This is somewhat puzzling considering a ZOI of 22mm is 
clinically relevant in the context of standard antibiotic susceptibility, given that imipenem 
is susceptible with a zone of ≥ 19mm and colistin is susceptible with a zone of  ≥ 11mm. 
P. aeruginosa was resistant to both of these antibiotics, yet, using these interpretive 
criteria, would have clearly been considered susceptible to cinnamon bark. There could 
be several reasons for this type of discrepancy in our study. Firstly, diffusion kinetics 
from a disk on the agar surface will be different than the diffusion kinetics when 
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incorporated into solid agar. It is possible that the difference in diffusion kinetics played a 
role in this discrepancy. Given that this was not a consistent finding with cinnamon bark 
in any other organism tested, it is likely more a question of differences in the way the EO 
accesses the bacterium; a given bacterial species may be more or less resistant to an EO 
based on its method of delivery.  
Interpretation of synergy testing. The combination of an aldehyde, a phenol, and a 
tropolone very often yielded greater activity than any of these EO compounds on their 
own. It is very likely that the mechanisms of each are synergistic with the others in a 
manner that allows more efficient penetration of the bacterial cell. For example, a 
phenolic EO that causes pore formation in the cell membrane may allow for greater and 
more expedient transfer of the aldehyde EO and/or the tropolone EO into the cell, 
resulting in increased bacterial inhibition.  
Investigation of synergistic behavior of these EOs is critical, as the end goal is to 
create new and better therapeutic options for bacterial infection. Often, full 
concentrations of antimicrobial compounds, such as phenols, can be toxic and damaging 
to mammalian cells, resulting in unpleasant side effects of their use. Through our synergy 
testing, we discovered that it is feasible to use dramatically lower concentrations of these 
oils and still inhibit MDR bacterial growth effectively. While these studies are purely 
introductory and done only in-vitro, our results to date are promising for the prospects of 
future in-vivo studies and translation to clinical therapy. Further elucidation of the 
specific mechanism underlying the potent activity of individual aldehydes as 
demonstrated in this study may provide the basis for identification of novel antibiotic 








Table 6: Relative Inhibition of Various Essential Oils Against a Clinical 
Strain of A. baumanii 
 
Numbers indicate zones of inhibition in mm as determined by modified disk 
diffusion, with 6mm denoting the size of the paper disk, and no inhibition of 
growth. EO’s are arranged in most potent to least potent from top to bottom, 
reading left to right. 
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Table 7: Relative Inhibition of Various Essential Oils Against Four Strains of 
Clinical Enteric Bacteria 
 
Numbers indicate zones of inhibition in mm as determined by modified disk diffusion, 
with 6mm denoting the size of the paper disk, and no inhibition of growth. EO’s are 
arranged in most potent to least potent from top to bottom, reading left to right.  
Means represent the average zone size for all four organisms considered together. 




Essential Oil MRSA 
1X 1:2 1:4 1:8 
Cilantro 100 100 41 12 
Lemon Myrtle 36 0 21 16 
Litsea 25 21 9 0 
Lemongrass 7 2 0 0 
Catnip 39 0 0 0 
Cassia 100 100 0 0 
Thyme 73 28 35 18 
Oregano 100 31 11 0 
Arborvitae 50 99 91 51 
Cinnamon Bark 100 19 0 22 
Essential Oil ENCL 
1X 1:2 1:4 1:8 
Cassia 100 38 0 37 
Cinnamon Bark 44 43 0 0 
Oregano 54 44 48 22 
Thyme 44 48 25 0 
Arborvitae 48 3 0 0 
Clove 51 41 10 0 
Tea Tree 0 0 0 0 
Camphor 0 0 0 0 
Marjoram 0 0 0 9 
Lime 0 0 0 0 
Table 10: Percent Inhibition of MRSA by the Top 10 Most Inhibitory EO’s 
for this Organism.  
 
Numerical values represent percentage of bacterial growth inhibited. 
Table 11: Percent Inhibition of E. cloacae by the Top 10 Most Inhibitory 
EO’s for this Organism. 
 
Numerical values represent percentage of bacterial growth inhibited. 
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Essential Oil NDM1 
1X 1:2 1:4 1:8 
Cassia 100 0 0 0 
Cinnamon Bark 3 0 21 0 
Arborvitae 0 0 0 0 
Cypress 0 ND 0 0 
Camphor 49 9 5 0 
Oregano 13 0 0 0 
Thyme 0 0 0 0 
Clove 0 0 6 30 
Tea Tree 0 0 0 0 
Wintergreen 0 0 0 0 
Essential Oil PSAE 
1X 1:2 1:4 1:8 
Cassia 53 0 0 0 
Cinnamon Bark 0 0 0 0 
Thyme 0 0 0 0 
 
Table 12: Percent Inhibition of S. enterica by the Top 10 Most Inhibitory 
EO’s for this Organism. 
 
Numerical values represent percentage of bacterial growth inhibited. ND: 
no data available. 
 
Table 13: Percent Inhibition of P. aeruginosa by the Top 3 Most Inhibitory 
EO’s for this Organism. 
 




ENCL  Cas1:2/AV1x/O1:4 Cas1:2/AV1x Cas1:2/O1:4 
Plate 1 ND 184 222 
Plate 2 199 178 206 
Average 199 181 214 
% Inhibition 27.9 34.4 22.5 
NDM1  
Plate 1 148 ND ND 
Plate 2 86 57 102 
Average 117 57 102 
% Inhibition 8.6 55.5 20.3 
MRSA  Cil1:4/AV1:8/O1:4 Cil1:4/AV1:8 Cil1:4/O1:4 
Plate 1 0 0 1 
Plate 2 0 0 8 
Average 0 0 5 
% Inhibition 100 100 98.6 
Table 14: Viable Counts and % Inhibition of E. cloacae and S. enterica by EO 
Combinations.  
Plate 1, Plate 2, and Average rows represent number of colonies manually counted. % 
Inhibition numerical values represent the percentage reduction in growth over control. 
ENCL: E. cloacae, NDM1: S. enterica, Cas: cassia, AV: arborvitae, O: oregano, ND: no 
data. 
Table 15: Viable Counts and % Inhibition of MRSA by EO Combinations.  
 
Plate 1, Plate 2, and Average rows represent number of colonies manually counted. % 
Inhibition numerical values represent the percentage reduction in growth over control. 





PSAE  Cas1x/AV1x/Thy1x Cas1x/AV1x Cas1x/Thy1x 
Plate 1 0 15 82 
Plate 2 0 158 13 
Average 0 87 48 
% Inhibition 100 84.0 91.2 




Plate 1 ND 199 
Plate 2 0 237 
Average 0 218 
% Inhibition 100 21.0 
NDM1  
Plate 1 ND ND 
Plate 2 0 151 
Average 0 151 
% Inhibition 100 0 
Table 16: Viable Counts and % Inhibition of P. aeruginosa by EO Combinations.  
 
Plate 1, Plate 2, and Average rows represent number of colonies manually counted. 
% Inhibition numerical values represent the percentage reduction in growth over 
control. PSAE: P. aeruginosa, Cas: cassia, AV: arborvitae, Thy:  thyme. 
 
Table 17: Viable Counts and % Inhibition of E. cloacae and S. enterica by 
EO Combinations at Varying Volumes 
Plate 1, Plate 2, and Average rows represent number of colonies manually 
counted. % Inhibition numerical values represent the percentage reduction in 
growth over control. 15µl or 6.7µl of each oil in the combinations were added 
to liquid media. ENCL: E. cloacae, NDM1: S. enterica, Cas: cassia, AV: 
arborvitae, O: oregano, ND: no data available. 
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ENCL  O1:4 Cas1:2 AV1x 
Plate 1 144 37 191 
Plate 2 155 55 133 
Average 150 46 162 
% Inhibition 7.4 71.6 0 
 
 Cas1:2/O1:4 Cas1:2/AV1x Cas1x/AV1x/O1x 
(10µl) 
Plate 1 0 0 0 
Plate 2 0 0 0 
Average 0 0 0 
% Inhibition 100 100 100 
Table 18: Volume Investigation with Viable Counts and % Inhibition 
of E. cloacae by EO Dilutions and Combinations.  
EO volume added is 15µl per oil, except where 10µl per oil is specified. 
Plate 1, Plate 2, and Average rows represent number of colonies manually 
counted. % Inhibition numerical values represent the percentage reduction 




NDM1  O1:4 Cas1:2 AV1x 
Plate 1 98 0 66 
Plate 2 74 0 71 
Average 86 0 69 
% Inhibition 15.7 100 32.4 
 
 Cas1:2/O1:4 Cas1:2/AV1x Cas1x/AV1x/O1x 
(10µl) 
Plate 1 0 0 0 
Plate 2 14 0 0 
Average 7 0 0 
% Inhibition 93.1 100 100 
Table 19: Volume Investigation with Viable Counts and % Inhibition 
of S. enterica by EO Dilutions and Combinations.  
 
EO volume added is 15µl per oil, except where 10µl per oil is specified. 
Plate 1, Plate 2, and Average rows represent number of colonies manually 
counted. % Inhibition numerical values represent the percentage reduction 
in growth over control. Cas: cassia, AV: arborvitae, O: oregano.  
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Note: Aldehyde-containing EOs are represented by blue bars, phenolic-based EOs 
are represented by red bars, and tropolone-containing EOs are indicated by 
yellow bars. Positioning of individual bars indicates relative inhibition from 
greatest to weakest, reading from left to right.  
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Section IV 
Practical Application of an Essential Oil against a Fungal Pathogen of Agricultural 
and Human Importance 
 
Background  
Pseudogymnoascus destructans, previously known as Geomyces destructans, is a 
filamentous fungus, which is the causative agent of White-Nose Syndrome in bats. It is a 
cold-adapted, or psychrophilic, fungus that thrives in the cooler environment of bat 
hibernacula. Discovered in New York in 2006, P. destructans has since been identified 
across the country and internationally (Boire, 2013; Chaturvedi, 2010).  In North 
America, bat populations have been severely impacted with millions of animals having 
died in 29 states and 5 Canadian provinces (Chaturvedi, 2010; Lorch, 2013; Boire, 2016). 
Once a bat becomes infected, the mortality rate is close to 100%.  Infection results in 
premature emergence from the typical bat hibernation cycle, making it necessary for 
affected animals to survive in harsh winter conditions in the absence of their traditional 
food source. Infected bats often present with significant, obvious manifestations of 
disease, including skin lesions of penetrating, white fungal growth on the snout and 
wings, severe dehydration, and failure to thrive (Boire, 2016; Zhang, 2015; O’Donaghue, 
2015). The pathogenicity of P. destructans infection is not completely understood, 
however, it is known that gas exchange in bats occurs largely through the wing web, an 
area significantly impaired in infected bats whose wings are covered by mats of fungal 
growth. These fungal mats are thought to disrupt gas exchange, which leads to an 
increase in CO2 and consequently premature emergence from torpor. The accelerated 
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metabolism of awakened bats requires scavenging for food, which cannot be found in the 
winter months leading to significant numbers of deaths. In addition, O’Donaghue and 
colleagues (2015) discovered secretory proteins from P. destructans with redox and 
hydrolytic properties including one which likely breaks down collagen. Taken together, 
this would explain the high mortality observed in infected animals.  
Despite the devastating impact of P. destructans, no effective control measures 
have been identified or developed to date, thus the fungus continues to spread westward, 
across North America. This spread is facilitated not only by direct contact between bats, 
but also by the presence of bat ectoparasites resulting in movement of the fungus into 
naive regions (Lucan, 2016). Bats are important and essential members of a larger 
ecosystem and play a critical role in insect control and pollination. Thus it is crucial that 
we elucidate the pathology and epidemiology of this disease, and search for ways to 
intervene in the devastation this pathogen is causing before it is too late (Chaturvedi, 
2010).  
Previous research by our group demonstrated significant inhibition of P. 
destructans by cold-pressed, terpeneless, Valencia orange oil (CPT). Other investigators 
showed inhibition of P. destructans using volatile compounds produced by other 
microorganisms (Boire, 2016; Zhang, 2015). In the current study, we investigated the 
activity of CPT against a wide variety of bacteria and fungi, including Rhodococcus spp 






Materials and Methods 
 
Stability and potency of CPT. Stability testing of CPT involved three separate lots 
of CPT (Firmenich Citrus Center, Lakeland, FL): ‘Old CPT’ was manufactured ~5 years 
prior to this study; CPT 1 and CPT 2 were manufactured within a month of the start of 
this study. Potency of each lot was determined by creating two-fold dilutions of each lot 
in DMSO starting at 100% down to 6.25%  
Activity of CPT against various environmental bacteria. All testing was 
conducted using a modified Kirby-Bauer disk diffusion assay. Bacterial species selected 
for testing included Bacillus spp (3), Acinetobacter baumanii, Stenotrophomonas 
maltophila, Rhodococcus spp, Mycobacterium phlei and M. fortuitum, and Nocardia spp. 
Bacterial isolates were grown at 37◦C, for 24 hours (Bacillus, Acinetobacter, 
Stenotrophomonas), 3 days (Rhodococcus), or 5-6 days (Mycobacterium, Nocardia). For 
each isolate, with the exception of Mycobacteria and Nocardia, a 0.5 McFarland standard 
was prepared in MH broth (Becton Dickinson). McFarland Standards for Mycobacteria 
and Nocardia were prepared in Middlebrook 7H9 broth (Hardy Diagnostics, Santa Maria, 
CA). Rhodococcus, Mycobacterium, and Nocardia species required the addition of glass 
beads (1mm, Sigma-Aldrich, St. Louis, Missouri) and one minute of agitation via vortex 
to break up the colony and achieve an adequate bacterial suspension. Following 
vortexing, suspensions were allowed to settle for approximately ten minutes before 
turbidity measurements were taken of the supernatant.  
Adjusted suspensions were then inoculated onto 80 mm Mueller Hinton agar 
plates (Becton Dickinson) for bacteria or Middlebrook 7H10 agar (HiMedia Labs, VWR, 
Radnor, PA) for Mycobacteria and Nocardia. Lawns were plated by spreading the 
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inoculum evenly over the plate with a sterile swab, and a sterile paper disk was placed 
into the center of each plate. Subsequently, 10 µl of each CPT dilution to be tested (100% 
to 6.25%) was pipetted onto each paper disk and plates were left in the biological safety 
cabinet for ~10 minutes to dry followed by incubation at 35◦C which varied in length 
dependent upon the organisms being tested: Bacillus, Acinetobacter, and 
Stenotrophomonas spp were incubated for 24 hrs; Rhodococcus was incubated for 3 days; 
Mycobacterium and Nocardia spp were incubated for 5-6 days. After appropriate 
incubation, zones of inhibition surrounding the CPT impregnated paper disks were 
measured in mm and recorded. All assays were performed in duplicate.  
Activity of CPT against various environmental fungi. All testing was conducted 
using a modified Kirby-Bauer disk diffusion assay. Fungal isolates included in this 
analysis were A. niger, A. fumigatus, P. varioti, Scedosporium spp, Fusarium spp, and 
Paecilomyces spp. All fungal isolates were cultured on Sabouraud Dextrose agar (Becton 
Dickinson, Sparks, Maryland) for 7 days at 15◦C to allow sufficient growth and spore 
formation. Once grown, fungal spores were suspended in sterile water and vortexed with 
sterile glass beads (1mm, Sigma-Aldrich, St. Louis, Missouri) for one minute to eliminate 
clumps and obtain a uniform suspension. Following vortexing, all suspensions were left 
for approximately ten minutes to allow debris to settle out, and the supernatant was used 
to prepare the inoculum. A T20 spectrophotometer (Spectronic 20D+, Thermo Scientific, 
Waltham, MA) was used to adjust the supernatant to the appropriate optical density for 
each organism. Once the proper inoculum was created, fungal lawns were plated for each 
isolate to be tested. For all fungal plates, application of sterile, paper disks (6 mm, Becton 
Dickinson) and addition of experimental CPT dilutions (100% to 6.25%, twofold) 
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proceeded as delineated for bacterial testing. Plates were incubated at 25◦C for one week, 
and observed daily. When confluent growth was apparent on the control plates, zones of 
inhibition were measured (in mm) for all CPT lots and dilutions. Zones obtained with 
CPT were compared to amphotericin, posaconazole, and caspofungin, drugs with known 
antifungal activity, to place CPT zone sizes in clinical context. 
 
Results  
Activity of CPT against various environmental bacteria. Zone diameters for 100% 
old CPT, CPT 1 and 2, were larger than zones for the subsequent four serial dilutions on 
all species tested. Tables 1A and 1B show the average size of zones of inhibition, in mm, 
and range of zone sizes, for all bacteria with all lots of CPT tested. None of the zones of 
inhibition from any CPT lot against S. maltophila and A. baumanii were larger than 11 
mm. The three Bacillus species tested showed greater variation in zone size with the 
undiluted CPT lots, as evidenced by the much wider range; however, the average zone 
sizes and ranges decreased rapidly with subsequent dilutions. Individual Bacillus spp 
inhibition for all CPT lots is shown in Figure 1. A similar pattern was noted with the 
remaining organisms, Rhodococcus, Nocardia, M. phlei, and M. fortuitum. Despite being 
more susceptible to all three lots of CPT, on average, the zone sizes decreased 
dramatically once the oil was diluted. As shown in Figure 2 and Figure 3, slower growing 
bacteria were more susceptible to inhibition by all lots of CPT than faster growing 
bacteria (3 to 5 days, Rhodococcus, Nocardia, and Mycobacteria, vs 24 hrs S. maltophila, 
A. baumanii, and Bacillus spp). The newer lots of CPT (C1 and C2 in Tables 1A & 1B) 
showed greater inhibitory activity across the board than the older lot of CPT (CO in 
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Tables 1A & 1B), with CPT2 inhibiting bacterial growth slightly better than CPT1. 
Duplicate runs yielded consistent results for all bacterial species studied.   
Activity of CPT against various environmental fungi. Table 2 shows the zone 
sizes, in mm, obtained with CPT testing on selected environmental fungi.  Fungal isolates 
were more susceptible than even the slower growing bacterial species, with zones of 
inhibition ranging from nearly equivalent to the largest bacterial average zone size 
(~32mm) to 11mm larger, on average, with CPT2 (fungal range 31mm to 60mm). The 
patterns noted in bacterial inhibition held true for fungal testing as well, with newer CPT 
(C1 and C2 in Table 2) inhibiting fungi more effectively than older CPT (CO in Table 2), 
and CPT2 showing slightly better activity than CPT1. This pattern against the fungal 
isolates was subtle, as there was a great deal of variation, as shown in Figures 4A and 4B. 
CPT at 100% was generally more effective at inhibiting these environmental, filamentous 
fungi than any of the antifungal drugs tested; however, once CPT was diluted to 25%, it 
was no longer more effective than the antifungal drugs screened. Table 3 shows CPT2 at 
100% and 25% as compared to common antifungal drugs. At 100%, CPT2 yields an 
average zone of inhibition roughly twice the size of the most effective antifungal on this 
group of isolates (43 mm vs 24 mm, respectively), whereas 25% CPT2 yielded an 
average zone of inhibition of 18 mm. 25% CPT is slightly more inhibitory on P. 







Based on the data obtained from this study, it appears as though CPT has very 
specific inhibitory activity against P. destructans, the fungus that causes White-Nose 
Syndrome. Common environmental bacteria tested were not nearly as susceptible to the 
CPT as P. destructans has been. For example, P. destructans is completely inhibited by 
the newer lots of CPT at 100%, a level of inhibition not observed with any environmental 
bacteria tested. Additionally, at 50% and 25% concentrations of new CPT, zones of 
inhibition for P. destructans were generally twice as large, if not larger, than the 
corresponding zone with environmental bacteria (Boire, 2016). This suggests that even 
when diluted, CPT may maintain clinically relevant inhibitory effects on P. destructans, 
while having very little to no effect on a variety of bacteria sharing the same habitat. 
While CPT showed greater activity against environmental fungi, complete inhibition was 
not observed on any of the fungal isolates tested, as it was for P. destructans. 
Additionally, the observation that diluted CPT remains more effective on P. destructans 
than environmental fungi or bacteria is important for its potential therapeutic use. If CPT 
were to be a viable preventive treatment against P. destructans in the field, it needs to 
have minimal effect on the natural microbial ecosystem of the hibernacula. From these 
results, it seems that there would be little to minor collateral damage caused by use of 
CPT in the natural environment at the lowest effective dilution.  Future field studies will 
examine this possibility. 
 Further testing of CPT will include additional and repeat studies into the effects 
on the microbial ecosystem likely to be found inside the bat hibernacula. In addition, 
studies will be performed to assess any harmful effects of CPT on bats and including 
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toxicity and induction of aversion behavior. Finally, should CPT have no observed 
detrimental consequences in bats, potential application strategies for effective dispersal in 






















DMSO 6.0 6.0-6.0 6.0 6.0-6.0 6.0 6.0-6.0 6.0 6.0-6.0 
CO 1X 8.5 8.0-9.0 7.0 6.0-8.0 21.8 15.0-36.0 18.0 
17.0-
19.0 
CO-1 8.3 8.0-8.5 7.0 6.0-8.0 11.8 6.0-14.0 13.5 13.0-14.0 
CO-2 8.0 7.0-9.0 6.0 6.0-6.0 8.3 6.0-10.0 12.5 12.0-13.0 
CO-3 8.0 8.0-8.0 6.0 6.0-6.0 6.3 6.0-7.0 10.5 9.0-12.0 
CO-4 6.5 6.0-7.0 6.8 6.0-7.5 6.6 6.0-9.0 7.5 7.0-8.0 










C1-2 9.5 9.0-10.0 7.8 6.5-9.0 10.3 6.0-12.0 14.0 
13.0-
15.0 
C1-3 8.5 8.0-9.0 6.0 6.0-6.0 6.8 6.0-10.0 8.5 8.5-8.5 
C1-4 7.8 7.5-8.0 6.0 6.0-6.0 7.0 6.0-8.0 8.0 8.0-8.0 












C2-2 8.0 8.0-8.0 6.0 6.0-6.0 7.3 6.0-9.0 11.8 10.5-13.0 
C2-3 7.8 7.5-8.0 6.0 6.0-6.0 6.7 6.0-9.0 7.0 6.0-8.0 
C2-4 7.0 6.0-8.0 6.0 6.0-6.0 6.8 6.0-9.0 6.0 6.0-6.0 
Table 1A: Average Zone Size (ZOI - mm) and Zone Size Range for Each CPT 
Lot and Corresponding Dilutions on Environmental Bacteria.  
A zone size of 6mm indicates confluent growth up to the disk and no observed 

















DMSO 6.0 6.0-6.0 6.0 6.0-6.0 6.0 6.0-6.0 
CO 1X 17.5 17.0-18.0 19.5 19.0-20.0 18.0 16.0-20.0 
CO-1 13.0 12.0-14.0 13.5 13.0-14.0 13.0 13.0-13.0 
CO-2 10.0 10.0-10.0 11.5 11.0-12.0 12.0 12.0-12.0 
CO-3 9.0 9.0-9.0 10.0 10.0-10.0 9.0 9.0-9.0 
CO-4 8.0 8.0-8.0 8.0 8.0-8.0 7.0 7.0-7.0 
C1 1X 32.5 27.0-38.0 28.0 27.0-29.0 31.5 29.0-34.0 
C1-1 15.0 14.0-16.0 18.0 18.0-18.0 16.0 16.0-16.0 
C1-2 11.5 11.0-12.0 13.0 12.0-14.0 13.5 13.0-14.0 
C1-3 9.5 9.0-10.0 11.0 10.0-12.0 9.0 9.0-9.0 
C1-4 8.3 8.0-8.5 9.0 9.0-9.0 6.0 6.0-6.0 
C2 1X 30.5 27.0-34.0 27.5 25.0-30.0 31.5 29.0-34.0 
C2-1 14.0 14.0-14.0 17.0 16.0-18.0 15.0 15.0-15.0 
C2-2 10.0 10.0-10.0 11.0 11.0-11.0 11.5 11.0-12.0 
C2-3 10.0 10.0-10.0 10.5 10.0-11.0 6.0-6.0 6.0-6.0 
C2-4 8.0 8.0-8.0 7.5 7.0-8.0 6.0-6.0 6.0-6.0 
Table 1B: Average Zone Size (ZOI - mm) and Zone Size Range for Each 
CPT Lot and Corresponding Dilutions on Environmental Bacteria.  
 
A zone size of 6mm indicates confluent growth up to the disk and no observed 














Figure 1: Comparison of the Activity of Three Lots of CPT Against Three Bacillus 
spp. Average zone size (mm) is represented for each species, under each experimental 




Figure 2: Inhibition of Slow-Growing Bacteria using Three Different Lots of CPT. 
Average zone size (mm) is represented for each organism, under each experimental 





































































































































































Figure 3: Inhibition of Fast-Growing Bacteria using Three Different Lots of CPT. 
Average zone size (mm) is represented for each organism, under each experimental 
condition. CO: Old CPT, C1: CPT1, C2: CPT2, DMSO: dimethyl sulfoxide. 
 
 
Figure 4A: Inhibition of Environmental Fungi using Three Different Lots of CPT. 
Zone size (mm) is represented for each fungal isolate under each experimental condition. 
Amphotericin was used for a comparison of known anti-fungal activity. CO: Old CPT, 
C1: CPT1, C2: CPT2, DMSO: dimethyl sulfoxide, AmpB: amphotericin B, PosC: 











































































































































































Figure 4B: Inhibition of Environmental Fungi using Three Different Lots of CPT. 
Zone size (mm) is represented for each fungal isolate under each experimental condition. 
Amphotericin was used for a comparison of known anti-fungal activity. CO: Old CPT, 
























































































Glossary of Abbreviations 
 
ACBA:  Acinetobacter baumannii 
CB:  Chesapeake Bay 
CFU/ml:  Colony-forming units per milliliter 
CLSI:  Clinical and Laboratory Standards Institute 
CPT:  Cold pressed, terpeneless Valencia orange oil 
DMSO:  Dimethyl sulfoxide 
ENCL:  Enterobacter cloacae 
EO:  Essential oil 
KLPN:  Klebsiella pneumoniae 
MDR:  Multi-drug resistant 
MH:  Mueller Hinton 
MIC:  Minimum inhibitory concentration 
MRSA:  Methicillin-resistant Staphylococcus aureus 
NDM1:  Salmonella enterica (NDM-1 +) 
PSAE:  Pseudomonas aeruginosa 
Spp:  Species 
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 The causative agent of White Nose Syndrome (WNS), Pseudogymnoascus 
destructans, has been shown to be fatal to several species of bats in North America.  To 
date, no compounds or chemical control measures have been developed which eliminates 
the growth of the fungus in the environment or in affected animals.  In the current study, 
we evaluated the activity of cold-pressed, terpeneless orange oil (CPT) against multiple 
isolates of P. destructans in vitro. For all assays, a modified Kirby-Bauer disk diffusion 
assay was used.  Standardized spore suspensions were prepared, adjusted to a specific 
optical density, and used to plate fungal lawns.  Plates were incubated at either 15◦C or 
4◦C for up to 6 months and checked at regular intervals for growth.  Once controls had 
grown, zones of inhibition were measured (mm) on test plates and compared to those 
obtained using current antifungal drugs.   All P. destructans isolates were completely 
inhibited by 100% CPT (10 µL) at 1 month of incubation regardless of temperature (4C 
and 15C).  Complete inhibition persisted up to 6 months following a single exposure at 
this concentration. Of the standard antifungals, only amphotericin B demonstrated any 
activity, resulting in zone diameters ranging from 58 mm to 74 mm. CPT, at the highest 
concentration tested (100%), had no significant effect against a variety of other 
environmental organisms including various filamentous fungi, bacteria and aerobic 
actinomycetes.  Given that CPT is relatively non-toxic, the possibility exists that the all-
natural, mixture could be used as an environmental pre-treatment to eradicate P. 
destructans from bat habitats.  Additional studies are needed to assess any undesirable 
effects of CPT on bat behavior and health and overall impacts on other members of the 




White-nose syndrome (WNS) is a lethal disease in bats caused by a psychrophilic 
(cold-adapted) fungus, Pseudogymnoascus destructans (synonym: Geomyces 
destructans).  To date, this fungus has killed an estimated 7 million bats in North 
America since first being identified from a solitary New York cave system in 2006 [1-8].  
At the time of this writing, P. destructans has been identified in 29 states and 5 Canadian 
provinces [9].  Bat populations have been decimated and are continuing to rapidly decline 
due to a mortality rate of nearly 100 percent [1, 5, 6, 7, 10, 11].  WNS currently affects 
seven species of bats, with at least two officially labeled as endangered, including the 
Indiana bat [1, 5-7].  The infection causes the premature emergence of bats from their 
hibernation cycle, forcing them to survive in winter in the absence of their traditional 
food supply being available.  Afflicted bats often appear emaciated exhibiting significant 
dehydration, with external epidermal lesions and white fungal growth appearing on their 
snouts [12-15].  Due to the current and potentially devastating ecological impact and 
severity posed by this pathogen, organizations from every level of government and 
private environmental conservation groups have come together to develop strategies for 
controlling WNS infection and spread, including the U.S. Fish and Wildlife Service, the 
National Park Service, the Department of Agriculture, and Bat Conservation International 
to name a select few [16].  The U.S. Fish and Wildlife service has awarded grants totaling 
more than $950,000 in 2013 alone to 28 states specifically designated for WNS 
eradication projects [17].   Funding for WNS research includes the study of its 
epidemiology, pathogenicity, host immunology, and the further development of 
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biological intervention and countermeasures to control and prevent the spread of this 
deadly fungus.  Recently, investigators demonstrated potential biological control of P. 
destructans by Rhodococcus rhodochrous which produced contact-independent activity 
against this wildlife pathogen [18].  However, no compounds or chemical treatments are 
currently described which successfully inhibit or control the growth of this fungus, either 
in the environment, or on the bats.  In the current study, we evaluated the activity of CPT 
against P. destructans isolates recovered from bats in diverse geographic locations within 
the continental US and a number of other commonly encountered environmental 
organisms including various filamentous fungi, bacteria, and aerobic actinomycetes.  
 
Materials and Methods 
A modified version of the Kirby-Bauer disk diffusion assay was used to determine 
the in vitro susceptibility of several isolates of P. destructans to CPT, a commercially 
available mixture prepared from Citrus sinensis by Firmenich Citrus Center, Lakeland, 
FL.  In total, 4 different lots were tested: two recently manufactured (< 1 month old), one 
~5 years of age, and one > 7 years.  Assessment of potency was done using 2-fold 
dilutions of each parent CPT mixture in DMSO beginning with 100% down to 0.19%.  
All dilution assays included a separate DMSO control.  For all assays, the type isolate of 
P. destructans (American Type Culture Collection, ATCC MYA-4855) and 6 wild 
isolates (Research Archive Collection of Dr. Kevin Keel, UC Davis School of Veterinary 
Medicine, Davis, California) were used, the latter having been obtained from diverse 
geographic locations as illustrated in Figure 1.  All P. destructans isolates were cultured 
on Sabouraud Dextrose agar (Becton Dickinson, Sparks, Maryland) for one week at 15◦C 
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to permit adequate sporulation for preparation of spore suspensions in sterile water.  To 
decrease clumping, suspensions were vortexed with sterile glass beads (1mm, Sigma-
Aldrich, St. Louis, Missouri) for one minute and allowed to settle for an additional ten 
minutes after which the supernatant was adjusted to an optical density of 0.09-0.13 at 530 
nm using a T20 spectrophotometer (Spectronic 20D+, Thermo Scientific, Waltham, MA).   
Adjusted suspensions were used to plate fungal lawns for each isolate tested to which 
were added sterile, blank filter disks (6 mm, Becton Dickinson).  For all assays, 10 L of 
CPT, ranging from 100% to 0.19%, were pipetted onto each blank disk and allowed to air 
dry in a biological safety cabinet for 10 minutes. For P. destructans, plates were 
incubated at 15C and 4C and examined daily for growth for the first 2 months and then 
weekly thereafter for a total of 6 months.  To control for CPT inhibition sensitive to 
differences in temperature and growth rate, both were monitored in untreated controls to 
determine the number of days required at 15C and 4C for the appearance of fungal 
colonies.  Once confluent growth was observed on control plates, the zone of inhibition 
was measured in mm for CPT and all other anti-fungal drugs tested. Zones obtained with 
CPT were compared to those resulting from standard antifungal drugs: amphotericin B 
(10 g, Rosco Diagnostics, Taastrup, Denmark), caspofungin, (5 g, Rosco Diagnostics), 
fluconazole (25 g, Becton Dickinson), and voriconazole (1 g, Becton Dickinson).  
These drugs were used as a comparative reference for CPT-mediated zones of inhibition 
to establish relative susceptibility or resistance since no current interpretive guidelines 
exist for this natural antimicrobial.  Interpretation of zone diameters for the standard 
antifungals was made using currently established breakpoints and recommendations as 
per the Clinical and Laboratory Standards Institute [19].  CPT was also tested against a 
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variety of other environmental filamentous fungi, bacteria and aerobic actinomycetes 
including: Aspergillus niger, A. terreus, and A. fumigatus, Scedosporium prolificans, 
Paecilomyces variotii, Fusarium solani, Bacillus spp., Acinetobacter baumanii, 
Stenotrophomonas maltophilia, Nocardia spp., Rhodococcus spp., and Mycobacterium 
fortuitum and M. phlei.  For these additional environmental organisms, inoculum 
preparation, incubation times, and conditions varied.  For all filamentous fungi, cultures 
and spore suspensions were prepared as above for P. destructans; plates were incubated 
at 25C and examined daily for growth for up to 1 week.  For Gram-positive and Gram–
negative bacteria, and Rhodococcus spp., all suspensions were prepared from 24 hour 
growth on solid media (Mueller-Hinton agar plates, Becton Dickinson) and adjusted to a 
0.5 McFarland turbidity standard in Mueller-Hinton broth (Becton Dickinson). 
Subsequently, lawns were plated onto Mueller-Hinton agar plates followed by the 
addition of blank, sterile disks and varying concentrations of CPT as described above.  
Plates were incubated at 35˚C and CPT-mediated zone diameters measured after 24 hours 
of incubation for all bacteria; 3 days for Rhodococcus spp.  For Nocardia spp. and 
Mycobacteria, suspensions were prepared from growth on Middlebrook 7H10 agar 
(HiMedia Labs, VWR, Radnor, PA) and adjusted to a 0.5 McFarland turbidity standard 
using Middlebrook 7H9 broth (Hardy Diagnostics, Santa Maria, CA).  Subsequently, 
lawns were plated onto organism-specific agar plates (bacteria, Mueller-Hinton agar; 
Nocardia and Mycobacteria, Middlebrook 7H10 agar) and the plates incubated at 25˚C 
for all filamentous fungi, and 35˚C for all bacteria, Nocardia, and Mycobacteria.  
Bacterial and filamentous fungal plates were read at 24 hours; Nocardia and 
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mycobacterial plates were read at 5 days and 7 days, respectively.  All assays were 
performed in triplicate.  
 
Results 
The difference in growth rate between the cold-adapted P. destructans isolates 
under the two temperatures studied was negligible.  At 15C, isolates grew in a complete 
lawn in an average of 21 days (range 18-24 days) and at 4C isolates demonstrated 
growth in an average of 28 days (range 25-31 days).  All P. destructans isolates tested 
were completely inhibited by 10 µL of 100% CPT at 1 month of incubation at both 15C 
and 4C.  Complete inhibition continued with this concentration of CPT (lots ≤ 5 years of 
age) for up to 6 months or the duration of the assay (Figures 2 and 3).  For the CPT lot > 
7 years of age, complete inhibition at the same concentration began to wane by the end of 
the second month of incubation with an average zone size of 60 mm (range 45 mm to 72 
mm); by month 4, the plates were completely overgrown.   When diluted to < 100%, the 
lots of CPT < 1 month of age demonstrated appreciable inhibitory activity at 3 months of 
incubation with average zone diameters ranging from 40 mm (range: 37 mm to 46 mm; 
50% CPT), to 18 mm (range: 6 mm to 13 mm; 6.25% CPT) (Table 1).  No inhibition was 
seen at concentrations < 6.25% (Table 1).  In contrast, the two older lots of CPT showed 
little to no inhibition of growth at any concentrations tested below 100% with average 
zone diameters at 3 months of incubation ranging from 15 mm (50% CPT) to 8 mm 
(6.25% CPT); no inhibition was demonstrated at concentrations < 6.25%.  No inhibition 
was observed in any of the assays with the diluent (DMSO) alone.  Of the standard 
antifungal agents tested, only amphotericin B demonstrated any inhibitory activity 
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against any of the P. destructans isolates tested over the course of the assay.  However, 
zone diameters did vary between isolates (15C, 42 days: range 58-65mm; 4C, 35 days: 
range 65-74 mm).  Caspofungin, voriconazole, and fluconazole failed to inhibit any P. 
destructans isolates regardless of time-point or incubation temperature (Figures 2 and 3).  
For the other environmental filamentous fungi, bacteria, and aerobic actinomycetes 
tested, CPT had little to no effect with zone diameters ≤ 15 mm following exposure to 10 
µL of 100% CPT.     
 
Discussion 
Since its discovery in 2006, WNS has killed millions of bats throughout North 
America. The effects of this devastating pathogen are immense, and may cause profound 
environmental, economic, agricultural, and public health impacts.  Bats play a critical 
role in their respective ecosystems.  Insectivorous bats consume incredible amounts of 
insects with some eating the equivalent of half their body weight per night [20]. Increased 
insect populations may result in significant agricultural losses and costs due to the 
requirement for more pesticides as well as detrimental effects on public health as insect 
vectors of infectious diseases could be expected to increase.  Current estimates postulate 
the possible damage to agriculture to range from a low of $3 billion to a high of $53 
billion per year [21].  Still to be determined are the ramifications to public health [21].  
Thus, it is vital that efforts continue to discover a means to combat and control this 
deadly fungus. 
In the current study, exposure of all isolates of P. destructans to 100% CPT (10 
µL) ≤ 5 years of age resulted in complete inhibition of fungal growth up to 6 months of 
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incubation following a single exposure regardless of temperature (15◦C or 4◦C).  At 
concentrations < 100%, only the CPT lots < 1 month of age demonstrated any activity 
with no inhibition observed at concentrations < 6.25%.  Taken together, this suggests that 
CPT is relatively stable at room temperature for up to 5 years with no significant loss in 
potency when used full strength (100%).  However, when diluted below 100%, only the 
lots < 1 month of age maintained significant anti-P. destructans activity, indicating that 
the older lots have lost potency over time, especially with regard to the lot > 7 years of 
age.  This is not unexpected as even under refrigerated storage conditions, many of the 
compounds in the parent CPT mixture would be expected to oxidize over time.   
Importantly, none of the commercially available antifungals used as a comparator in this 
study, showed similar activity in vitro at the same time-point, including fluconazole and 
voriconazole, which had been shown previously to be inhibitory to P. destructans [22].  
This discrepancy may be related to methodological differences in the assays performed: 
E-test and microbroth dilution used in the earlier investigation versus the modified Kirby-
Bauer method employed in the current study.  Additionally, the time-points at which 
assays were read and interpreted varied between the two investigations.  For example, in 
the prior study, endpoints were read and interpreted after 10 to 14 days of incubation at 
15◦C; after 21 days at 6◦C.  In the current study, plates were read and interpreted 
following a minimum of 21 days, extending out to 6 months which may explain the 
decreased inhibition of fluconazole and voriconazole as observed in this investigation.  In 
addition, dissimilarities in the in vitro activity of CPT versus the other drugs used in this 
study may also be due to potential differences in both the mechanism of action of CPT 
versus the current antifungals as well as the relative concentrations used of each.  The 
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specific mechanism of action of amphotericin B, fluconazole, voriconazole and 
caspofungin have been well defined, however, determination of the mechanism of CPT-
mediated inhibition of P. destructans was beyond the scope of this current project.  
However, other investigators have previously speculated and or demonstrated that CPT 
affects several key cellular processes such as membrane maintenance and integrity as 
well as ATP production and metabolism in target organisms [23-25].  For instance, 
transcriptional profiling in Staphylococcus aureus exposed to CPT revealed changes in 
cell wall-associated genes leading the authors to conclude that the primary effect of CPT 
was on the cell wall [23].  In mycobacteria, including M. tuberculosis and M. bovis BCG, 
CPT-specific effects were noted in ATP synthesis and associated downstream energy-
dependent metabolic processes such as mycolic acid production [24].  Similar studies 
demonstrated membrane-active effects from essential oils in various microorganisms 
resulting in disruption of membrane integrity and or permeability [26-28].  Of the 
commercially available antifungals used for comparison purposes in this study, only 
amphotericin B, which binds to ergosterol, showed any demonstrable activity in vitro.  
None of the remaining antifungals, which inhibit ergosterol or glucan synthesis, had any 
activity against P. destructans.  Taken together, this suggests that the CPT-mediated 
inhibition of P. destructans, may be due to a mechanism of action which differs from that 
of current antifungal drugs.      
Unlike antibiotics, essential oils, including CPT, are complex mixtures of 
compounds, some of which are volatile. Most are ‘generally regarded as safe’ (GRAS) by 
the FDA and are frequently used as flavoring agents in foods, cosmetics, and also 
cleaning products.  In fact, some oils are currently being investigated as potential 
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alternatives to conventional pesticides due to their low toxicity and a more favorable 
impact on the environment [29].  Although the specific effect of CPT on bats is not 
known, it has been shown to be non-toxic to mammalian keratinocytes at concentrations 
sufficient to eliminate S. aureus, prompting the authors to suggest its use as a topical 
antimicrobial against this specific pathogen [30].  Additional testing is needed to 
determine if CPT is equally non-toxic to bats.   
In summary, these results demonstrate that CPT-mediated inhibition of P. 
destructans is possible in vitro and persists up to 6 months at optimal incubation 
temperatures required for growth following a single application.  As such, CPT may 
provide a novel chemical means to help control this deadly fungus in the environment, 
without disturbing beneficial bacteria such as R. rhodochrous, which has been shown to 
have contact-independent activity against P. destructans.  Significant research is still 
needed to determine if any of the volatile components of CPT are sufficient for killing P. 
destructans, the effect(s) on bat behavior and physiology, as well as the impact on related 
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Figure 1.  The continental United States, highlighting sites from which the P. 
destructans isolates were obtained for the current study and current states with 
confirmed cases of White Nose Syndrome.  Isolate #1: Pocahontas County, West 
Virginia.  Isolate #2: Monongalia County, West Virginia.  Isolate #3: Lawrence County, 
Ohio.  Isolate #4: Trigg County, Kentucky.  Isolate #5: Montgomery County, Tennessee.  
Isolate #6: Jackson County, Alabama. The ATCC type isolate (MYA-4855) was 
previously recovered from Ulster County, New York.  Lightly shaded states represent 
those with confirmed cases of White Nose Syndrome in bats caused by P. destructans; 
darker shaded states represent those most recently confirmed for positive identification of 
the fungus. 
Figure 2. Inhibitory effect of cold-pressed, terpeneless Valencia orange oil against 
the type isolate (ATCC MYA-4855) of P. destructans after 6 months incubation at 
4°C.   A) untreated control; B, 100% CPT (10 µL);  C) amphotericin B (10 g/mL); D, 
fluconazole (25 g/mL); E, voriconazole (1 g/mL); and F, caspofungin (5 g/mL). 
Figure 3. Inhibitory effect of cold-pressed, terpeneless Valencia orange oil against a 
wild isolate of P. destructans (Pd #13) after 6 months incubation at 4°C.   A) untreated 
control; B, 100% CPT (10 µL);  C) amphotericin B (10 g/mL); D, fluconazole (25 




Table 1.  Inhibitory effect of various % concentrations of CPT (< 1 month of age) 




(Zone diameters in mma) 
100% 50% 25% 12.5%  6.25% ≤ 3.0% 
ATCC (MYA-
4855) 
80b ± 0.0 42 ± 2.5 26 ± 2.6 19 ± 1.2 11 ± 0.9 6c ± 0.0 
Pd04 80 ± 0.0 43 ± 3.2 22 ± 3.1 15 ± 1.2 6 ± 0.0 6 ± 0.0 
Pd13 80 ± 0.0 37 ± 7.5 30 ± 3.7 18 ± 1.6 6 ± 0.0 6 ± 0.0 
Pd17 80 ± 0.0 39 ± 2.5 21 ± 2.9 8 ± 1.2 12 ± 1.6 6 ± 0.0 
Pd21 80 ± 0.0 46 ± 6.0 15 ± 0.5 19 ± 1.2 13 ± 1.9 6 ± 0.0 
Pd39 80 ± 0.0 37 ± 6.2 12 ± 1.6 16 ± 2.1 11 ± 1.9 6 ± 0.0 
Pd52 80 ± 0.0 38 ± 6.7 18 ± 2.4 16 ± 3.0 12 ± 1.7 6 ± 0.0 
 
aInhibition zones (mm) are average values of three separate assays ± the standard 
deviation of the mean. 
bA zone diameter of 80 mm = complete inhibition, no growth visualized on the entire 
plate. 
cA zone diameter of 6 mm = no inhibition seen, a confluent lawn visible; 6 mm is 
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